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ABSTRACT 
CONTINUOUS POSITIVE AIRWAY PRESSURE USE AND MILD OBSTRUCTIVE 
SLEEP APNEA SYNDROME (OSAS) 
by 
Michelle L. Nelson 
 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Jennifer Doering, PhD, RN 
Obstructive sleep apnea syndrome (OSAS) is an increasingly recognized sleep disorder 
that affects an estimated ten percent of middle-aged women and 25 percent of middle-
aged men. Continuous positive airway pressure (CPAP) is the standard treatment for 
individuals with moderate to severe OSAS. However, it is estimated that 80 percent of 
individuals with OSAS have a milder form of the disease. The use of CPAP therapy in 
persons with mild OSAS has not been widely researched and whether CPAP is 
efficacious in this population remains inconclusive. OSAS has both psychological and 
physiological effects on people. Two common effects of CPAP use in persons with 
moderate and severe OSAS are reduced excessive daytime sleepiness (EDS) and reduced 
blood pressure. The purpose of this study was to examine the relationship of CPAP use to 
the outcomes of EDS and blood pressure in persons with mild OSAS. CPAP use was 
defined as using CPAP for more than 4 hours per night for more than 70 percent of nights 
recorded by the CPAP machine.  
The study design was a retrospective chart review of electronic medical records 
(EMR) from a sleep medicine clinic in the southeastern United States. The sample 
consisted of 60 participants with mild OSAS who were divided into two groups based 
upon the amount of CPAP use recorded in the EMR (4 or more hours of nightly use 70% 
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of nights, n = 45 and less than 4 hours of nightly use 70% of nights, n = 15). Blood 
pressure (systolic and diastolic) and daytime sleepiness (Epworth Sleepiness Scale) data 
were collected on each participant before the initiation of CPAP therapy and at six weeks 
follow up. Independent samples t-tests were conducted to examine the differences 
between the groups from baseline to six-week follow-up on the outcome variables. No 
statistical significance was found for daytime sleepiness (t [34] = .865, p = .393) or either 
systolic (t [52] = .911, p = .367) or diastolic (t [52] = 1.002, p = .321) pressures. 
Sleepiness scores in the group who used CPAP four or more hours a night 70% of nights 
decreased 6.6 points from baseline to 6 weeks, and decreased 8.1 points in the group who 
used CPAP less than 4 hours a night 70% of the nights. Both groups experienced 
clinically significant decreases in daytime sleepiness from nearly excessive daytime 
sleepiness (ESS score >10) before CPAP initiation to nearly no daytime sleepiness at six 
weeks follow up. There were significant limitations in data collection around both the 
EMR and the CPAP machine reporting that have implications for practice, research, and 
policy. Recommendations include standardization of CPAP use reporting across machine 
type, clearly defining the role of the nurse in the care of OSAS patients, and improving 
quality around data entry in the EMR. These results support the continued need to 
research the effectiveness of CPAP in persons with mild OSAS.  
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CHAPTER ONE 
STATEMENT OF THE PROBLEM 
Introduction 
Obstructive sleep apnea syndrome (OSAS) is an increasingly recognized sleep 
disorder that is estimated to affect 10 percent of middle-aged women and 25 percent of 
middle-aged men (Yu & Berger, 2011). OSAS is characterized by repeated episodes of 
collapse or narrowing of the upper airway during sleep that result in fragmented sleep,  
blood oxygen desaturations, and sympathetic activation (Fletcher, 2000; Young, Peppard, 
& Gottlieb, 2002). Excessive daytime sleepiness (EDS) and hypertension are commonly 
associated with OSAS (Baguet, Barone-Rochette, & Pepin, 2009; Rosenberg & 
Doghramji, 2009).  
EDS is the inability to stay alert and awake during the waking periods of the day, 
which often result in incidental lapses into sleep (Pagel, 2009). These periods may be 
accompanied by an uncomfortable feeling or struggle to stay awake when the sleep is 
inopportune. EDS also presents a safety concern when driving, operating machinery, and 
other similar activities. One of the leading causes of EDS is OSAS (Rosenberg & 
Doghramji, 2009).  
OSAS is a progressive disease that has many cardiovascular effects with one 
primary effect being hypertension. The European and American recommendations on 
hypertension recognize OSAS as an accepted cause of hypertension (Baguet et al., 2009; 
Mansia et al., 2007). Recent studies suggest that even mild forms of the disease may be 
correlated with hypertension (Barnes et al., 2002; Jaimchariyatam, Rodriquez, & Budur, 
2010). Hypertension can lead to damage to the structure and function of the eye (Wong & 
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Mitchell, 2007), stroke, cardiovascular disease (Woo et al., 2014), and kidney disease 
(Lim et al., 2012).   
Diagnosis of OSAS 
 The number of persons identified with OSAS is expected to rise considerably in 
the coming years. This is due in part to heightened awareness and increased screening 
and diagnosis, which in turn, will lead to a rise in the actual number of patients diagnosed 
with OSAS (Holmdahl et al., 2009). The increase in the number of patients with OSAS 
will place a considerable demand on the health care system. The presence of OSAS is 
frequently initially recognized by the daytime experience (excessive daytime sleepiness) 
of the patient or the nighttime sleep disturbance experienced by the bed partner. Classic 
nighttime symptoms include nocturnal awakenings, gasping during the night, apneas 
witnessed by bed partner, and loud snoring (Wenner, Cheema, & Ayas, 2009).  
 Diagnosis of OSAS is based primarily on the number of apnea-hypopnea events 
per hour an individual has during sleep as measured objectively by an overnight sleep 
study. An apnea is defined as the cessation of airflow for a time of at least 10 seconds. A 
hypopnea exists when either there is a 30 percent decrease in airflow from baseline, for a 
minimum of 10 seconds duration, with at least 4 percent desaturation from baseline, or 
there is at least 50 percent decrease in airflow for a minimum of 10 seconds duration with 
at least a three percent desaturation or an arousal (American Academy of Sleep Medicine, 
2007). Apneas and hypopneas are based on laboratory findings. The severity of the 
disease is determined by the apnea-hypopnea index (AHI) (i.e., the number of apneas 
plus hypopneas per hour of documented sleep). According to the American Academy of 
Sleep Medicine guidelines, OSAS can be diagnosed when the AHI is equal to or greater 
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than 15 or when the AHI is equal to or greater than 5 and accompanied by one or more of 
the typical associated symptoms of OSAS (witnessed apneas, regular snoring, excessive 
daytime sleepiness, restless sleep, fatigue or insomnia) (American Academy of Sleep 
Medicine, 2007). OSAS is further classified as mild, moderate, or severe. The severity of 
the disease is determined by the respiratory disturbance index (RDI). RDI is defined as 
the number of apneas, hypopneas, and respiratory effort related arousals (RERA) per 
hour of sleep. Mild OSAS is determined by a RDI of 5-14, moderate 15-30, and severe 
>30 (Epstein et al., 2009). Mild to moderate OSAS represents approximately 80 percent 
of the OSAS population (Young et al., 2008).  
 The most effective validated diagnostic tool for diagnosing OSAS is an overnight 
in-laboratory polysomnography (PSG) (Kushida et al., 2005). The PSG enables the 
practitioner to continuously monitor several physiologic variables including oxygen 
saturation, chest/abdominal movement, airflow, electroencephalography, and 
electromyography. The primary outcome measures examined from the PSG for a 
diagnosis of OSAS are: 1) AHI, 2) arousal index (a measure of sleep disruption per hour 
of sleep), and 3) various sleep scoring statistics describing overall sleep quality (e.g., 
sleep efficiency) (Ruehland et al., 2011). Many sleep laboratories also have an 
accompanying video and audio recording of the overnight session (Wenner et al., 2009).   
 Due to the resources required for PSG (personnel and laboratory availability), 
efforts have been made to develop and validate ambulatory devices that can be used to 
diagnose OSAS. In a population of patients where OSAS is likely (loud snoring, gasping 
during sleep, nocturnal awakenings, or witnessed apneas) an ambulatory study may 
provide sufficient evidence to initiate appropriate therapy (Mulgrew, Fox, Ayas, & Ryan, 
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2007). Ambulatory devices are capable of measuring many of the same physiologic 
variables as the overnight PSG. The primary difference is that ambulatory devices require 
fewer signals, which in turn allows them to be less expensive and more ambulatory 
(Domingo & Vigil, 2011). Ayas et al. (2003) found that the use of an overnight device 
worn on the wrist measuring physiologic markers of peripheral vasoconstriction and 
sympathetic activation in combination with oxygen desaturation index (number of > 4 
percent desaturations per hour) was a reasonably sensitive and specific means of 
diagnosing OSAS.  
Treatment of OSAS 
 Individuals diagnosed with OSAS are often treated with continuous positive 
airway pressure (CPAP) devices. CPAP acts as a pneumatic splint to prevent airway 
collapse during sleep by providing continuous pressure to the airway. The result is an 
increase in the actual size of the airway during treatment, primarily in the lateral 
direction, as well as decreasing lateral pharyngeal wall thickness and reducing airway 
edema associated with chronic vibration (snoring) and airway occlusion (Yagi et al., 
2009). CPAP therapy is not curative and could possibly be a lifelong treatment (Gami, 
Caples, & Somers, 2003; Schendel, Powell, & Jacobson, 2011). The guidelines for 
recommended CPAP use are 4 or more hours a night 70 percent of nights (Weaver & 
Grunstein, 2008).  
 The use of CPAP therapy for the treatment of patients with severe OSAS (apnea 
hypopnea index > 30) has been validated in the literature as being effective in reversing 
upper airway obstruction during sleep and also in reducing many of the troublesome 
consequences associated with this disorder, particularly, EDS (Antic et al., 2011; 
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Yaremchuk et al., 2011). However, the majority (80 percent) of individuals with OSAS 
has a milder form of the disease (apnea hypopnea index 5 - 30) (Young et al., 2005). 
CPAP therapy in persons with mild OSAS has not been widely used and previous 
research findings have been inconsistent in regards to the efficacy of CPAP in this 
population (Barnes et al., 2002; Engleman et al., 1997; Engleman et al., 1999; Marshall et 
al., 2005; Patel et al., 2003; Redline et al., 1998).  
Purpose 
 EDS is the inevitable result of insufficient sleep. Individuals who experience EDS 
are at risk of falling asleep inadvertently and at times, inappropriately. They often require 
naps during the day, either planned or unplanned, and can remain asleep for a variable 
amount of time. The struggle to stay awake during inopportune times is overwhelming 
and the individual experiencing EDS may feel as if they are losing a fight to stay 
connected to the external world. During this struggle for wakefulness attention 
diminishes, learning decreases, and memory is altered (Vernet et al., 2011). EDS can be 
physiological (underlying medical condition) or psychological (disturbed sleep) (Pagel, 
2009).  The researcher for this study is concerned with EDS as a psychological aspect of 
OSAS. The amount of subjective daytime sleepiness a person reports is influenced by the 
number of respiratory events (AHI) that occur during sleep (Hayashida et al., 2007).   
 Hypertension is clearly demonstrated to be associated with OSAS (Baguet et al., 
2009; Buchner et al., 2007; Jaimchariyatam et al., 2010; Mansia et al., 2007; Peppard et 
al., 2000). Effective treatment of OSAS with continuous positive airway pressure (CPAP) 
has been shown to dramatically and acutely decrease mean heart rate and decrease blood 
pressure throughout the day (Gapelyuk et al., 2011). The decrease in these two 
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physiological parameters suggests that cardiovascular consequences can be improved 
with adequate treatment of OSAS.  
 The progression of OSAS has been established in the literature (Berger, Berger, & 
Oksenberg, 2009; Fisher, Pillar, Malhorta, Peled, & Lavie, 2002; Pendlebury, Pepin, 
Veale, & Levy, 1997). Patients with untreated mild to moderate OSAS have been found 
to have an increase in AHI over time. More recently, Young et al. (2008) approximated 
the number of individuals with a mild to moderate form of OSAS to be 80 percent. Given 
the prevalence rates and the known progression of OSAS, it is imperative that additional 
studies involving patients with mild OSAS be conducted to assist in the establishment of 
guidelines for the treatment of OSAS in this population. 
 OSAS can lead to negative health outcomes at all levels of disease severity. The 
severity of OSAS depends on two separate parameters: AHI and level of EDS (Aurora et 
al., 2010). Being that OSAS is a progressive disease, diagnosis and treatment of OSAS in 
the mild form may prevent complications associated with EDS and hypertension by 
slowing or reversing the disease process. The purpose of this study was to examine the 
relationship of CPAP therapy on excessive daytime sleepiness and blood pressure in a 
population of patients with mild OSAS (AHI - 5-14). 
Research Questions 
To achieve the stated purpose, the research questions for this study were: 
1.) How does continuous positive airway pressure use affect daytime sleepiness 
in persons with mild obstructive sleep apnea syndrome?  
2.) How does continuous positive airway pressure use affect blood pressure in 
persons with mild obstructive sleep apnea syndrome? 
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Significance 
 The initial nursing assessment is a critical first step to identifying individuals with 
OSAS. Advanced practice nurses (APNs) are primary providers in physicians’ offices, 
clinics, as well as acute care and community-based settings. APNs have the opportunity 
to work with individuals with OSAS in the early stage of the disease process. These 
APNs are in a unique position to monitor patients, allowing opportunities for the 
detection of early signs and symptoms of OSAS, which may ultimately slow the 
progression of OSAS and its untoward effects. Routine nursing assessment in mild OSAS 
can identify risk factors associated with OSAS to include, but not limited to, metabolic 
syndrome, obesity, snoring, hypoxemia, apneic episodes, morning headaches, and 
hypertension. Risk identification and screening by APNs may enable patients to improve 
health outcomes over time through early diagnosis and ongoing monitoring and OSAS 
treatment. 
Healthcare providers specializing in sleep and sleep-related disorders have long 
been faced with the dilemma of when to treat OSAS. Historically, CPAP therapy has 
been reserved for patients with moderate to severe OSAS (AHI > 15). However, recent 
studies demonstrate that even minor degrees of sleep disordered breathing can be 
associated with an increased risk of motor vehicle accidents (Komada et al., 2009), 
hypertension (Laaban et al., 2010), significant cognitive effects (Mathieu et al., 2008), 
decrease in quality of life (Zamarron, Garcia Paz, & Riveiro, 2008), and an increase in 
EDS (Bixler et al., 2005). This evidence suggests that patients with a milder form of 
OSAS can potentially benefit from treatment with CPAP; however studies are needed to 
8 
 
 
 
show direct and indirect improvements in outcomes to determine whether CPAP should 
be a standard of care in mild OSAS. 
 In addition to the aforementioned, mild OSAS patients treated with CPAP have 
the following potential benefits. First, research suggests that OSAS progresses over time. 
Therefore, a patient that presents initially with simple snoring could likely evolve over 
the course of time to a mild, moderate, or severe OSAS patient without early intervention 
(Berger et al.,2009). Secondly, when comparing CPAP to a placebo, even in the mildest 
forms of the disease, treatment effect is clinically significant (Jaimchariyatam et al., 
2010). Thirdly, patients that present initially with mild OSAS have a high risk of 
developing hypertension due to the fact that even with low AHI levels cardiovascular 
risks can still exist (Takama & Kurabavashi, 2010). Lastly, excessive daytime sleepiness 
can be present in all forms of the disease. Patients that present with low AHI levels and 
report excessive daytime sleepiness have experienced significant relief of symptoms with 
adequate treatment (Barnes et al., 2002).  
 Treatment of patients with moderate to severe OSAS with CPAP therapy reverses 
upper airway obstruction while asleep as well as reducing many of the untoward side 
effects associated with OSAS such as excessive daytime sleepiness (Antic et al., 2011). 
The question of when to treat a patient with sleep apnea has long been debated and some 
research suggests that treating mild sleep apnea with CPAP is not warranted (Littner, 
2007). However, many researchers do support the use of CPAP in this population 
(Brown, 2007; Jaimchariyatam et al., 2010; Levy, Pepin, & McNicholas, 2002; Takama 
& Kurabayashi, 2010). It should be noted that OSAS is only cured in specific patient 
cases with craniofacial or upper airway surgery or significant weight loss. Therefore, 
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CPAP, though not curative, is the initial and gold standard treatment for patients with 
severe OSAS (Gami et al., 2003).  
Literature supporting the treatment of mild forms of OSAS is accumulating and 
clearly demonstrates that disease, even in this modest form, can lead to adverse 
symptoms and can be treated effectively. However, there remains a particular uncertainty 
regarding the effectiveness of CPAP therapy in mild cases of OSAS. Additional studies 
are needed to support the use of CPAP with this population providing supplemental 
evidence that increased adherence to CPAP in the mild OSAS population can lead to a 
decrease in EDS as well as a decrease in blood pressure. This study will help define the 
role of CPAP therapy and its effect on daytime sleepiness and blood pressure in this 
population.  
Definitions 
Sleep terminology is often used inconsistently across the sleep literature. For the 
purpose of this study the following definitions will be utilized.  
Obstructive sleep apnea syndrome (OSAS) is characterized by a number of 
symptoms including snoring, interrupted sleep pattern, intermittent breathing cessations, 
morning headaches, concentration and memory difficulties, irritability, and excessive 
daytime sleepiness (EDS) (Partinen & Hublin, 2005; Young et al., 2002). 
Excessive daytime sleepiness (EDS) refers to the tendency to fall asleep while 
involved in activities that are not stimulating, such as listening to a speaker or watching 
television (Rosenberg & Doghramji, 2009). 
Apnea is defined as the cessation of airflow for a time of at least 10 seconds 
(American Academy of Sleep Medicine, 2007).  
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 Hypopnea exists when either there is a 30% decrease in airflow from baseline, 
for a minimum of 10 seconds duration, with at least 4% desaturation from baseline, or 
there is at least 50% decrease in airflow for a minimum of 10 seconds duration with at 
least a 3% desaturation or an arousal (American Academy of Sleep Medicine, 2007). 
Apnea – hypopnea index (AHI) is a summary measure of the number of 
obstructive apnea and hypopnea episodes per hour of sleep (Chervin, 2005). 
 Polysomnography (PSG) is an overnight sleep study that involves simultaneous 
recordings of several physiologic functions during the sleep period, including the 
electromyogram (EMG), the electroencephalogram (EEG), electrooculogram (EOG), 
oronasal airflow assessments, and oxyhemoglobin saturation (Punjabi, 2008). 
 Electromyogram (EMG) measures muscle tone and is helpful in distinguishing 
between REM sleep and NREM sleep. Electrodes are placed 2 cm below the inferior 
edge of the mandible and 2 cm to the right and left of the midline of the mandible 
(Vaughn & Giallanza, 2008).  
 Electroencephalogram (EEG) measures electrical activity of the brain and is 
essential for staging the sleep cycle. The electrodes are placed between four primary skull 
landmarks (nasion, inion, and both auditory canals (Vaughn & Giallanza, 2008).  
 Electrooculogram (EOG) measures eye movement during sleep for the purposes 
of sleep staging. Electrodes are placed just outside the outer canthus of each eye with the 
right outer canthus being 1 cm above the horizontal midline and the left being 1 cm 
below the horizontal midline (Vaughn & Giallanza, 2008). 
 Respiratory Disturbance Index (RDI) is defined as the average number of 
respiratory disturbances (obstructive apneas, respiratory hypopneas, and respiratory 
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event–related arousals [RERAs]) per hour (Amfilochiou, Papagrigorakis, Georgopoulos, 
& Liolios, 2009).  
 Respiratory Effort Related Arousal (RERA) may be estimated by flattening of the 
inspiratory airflow profile associated with an arousal, when airflow changes do not meet 
apnea or hypopnea criteria or by changes in the esophageal pressure recording 
(Amfilochiou, Papagrigorakis, Georgopoulos, & Liolios, 2009).  
 Continuous positive airway pressure (CPAP) is a device that generates positive 
pressure in the airway in order to prevent collapse of the upper airway (Yagi et al., 2009). 
 Adherence with CPAP usage is defined as 4 hours or greater of nightly use 70 
percent of nights (Grunstein, 2005; Weaver & Grunstein, 2008). 
Summary  
 OSAS is a progressive disease with many adverse health outcomes. The 
implementation of CPAP therapy to persons with mild OSAS may slow the progression 
of the disease and promote health outcomes. EDS and hypertension are commonly 
associated with OSAS and will be the focus of this study. The researcher of this study 
will investigate one outcome each from the psychological (EDS) and physiological 
(blood pressure) aspects of OSAS, which will be placed within a theoretical framework in 
chapter 2 in addition to a review and analysis of the literature. A literature review will be 
provided in chapter two to support this study and the methods used to obtain and analyze 
the data will be addressed in chapter three. The results of this study will be presented in 
chapter four with a discussion of the findings to follow in chapter five.  
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CHAPTER TWO 
REVIEW OF LITERATURE 
 Obstructive sleep apnea syndrome (OSAS) is a progressive disease. Identifying 
and treating patients in the early stages of the disease can prevent numerous OSAS 
related health problems. The focus of this literature review is to provide an overview of 
the normal physiology of sleep and sleep regulation, discuss OSAS, and provide a review 
of CPAP as a treatment modality for OSAS.  
Physiology of Normal Sleep and Sleep Regulation  
A brief overview of the physiology of sleep is presented in order to lay the 
foundation of knowledge needed to establish the purpose for conducting the current 
study.  
Stages of sleep. There are two types of sleep, non-rapid eye movement (NREM) 
and rapid eye movement (REM) (Hauw, Hausser-Hauw, Girolami, Hasboun, & Seilhean, 
2011). The first type, NREM, is divided into four stages. The first stage of NREM sleep 
represents a small portion of sleep and occurs during the time the individual is falling 
asleep, approximately 5 percent of sleep occurs here.  During this stage the individual is 
easily aroused and if arousal does occur it may feel as if he/she has been daydreaming 
and not actually sleeping. Stage 2 NREM involves about 50 percent of sleep time and is 
often referred to as the time when true sleep occurs. Stages 3 and 4 NREM sleeps are 
deep stages of sleep and constitute approximately 10-20 percent of sleep. It is during 
Stage 3 NREM that complete muscle relaxation occurs, which assists the body in 
restoration through energy conservation. Stage 4 NREM is considered to be the deepest 
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stage of sleep; it is difficult to arouse someone during this stage of sleep. Stages 3 and 4 
usually occur within the first half of sleep time (Hauw et al., 2011).  
The second type of sleep accounts for approximately 20-25 percent of sleep and is 
referred to as REM sleep.  REM sleep alternates with NREM all through the sleep cycle.  
It most often begins within the first 90 minutes. It is during REM stage sleep that vivid 
full-color dreaming can occur. This stage is typified by the autonomic response of rapidly 
moving eyes, fluctuating heart and respiratory rates, and possibly an increase in blood 
pressure (Brown et al., 2012; Frey, 2001; Hauw et al., 2011).  
Regulation of sleep. The two-process model is commonly used to explain the 
regulation of sleep through homeostatic and circadian drives. The two-process model 
postulates that a relationship between the homeostatic drive to sleep (Process S) and the 
circadian drive to sleep (Process C) interact to support the process of sleep (Rusterholz, 
Durr, & Achermann, 2010). Process C and Process S are independent processes; yet work 
synergistically to promote sleep and wakefulness. Process S is a homeostatic drive to 
sleep (influenced by an individual’s history of sleep and waking), similar to a pressure 
system that builds during the waking hours of the day. Sleep pressure is released once a 
person falls asleep. Process C refers to the circadian rhythm.  
In the early morning hours the circadian rhythm encourages wakefulness, usually 
as a result of light (sunrise) which suppresses the release of melatonin. As the day 
becomes darker and melatonin levels increase so does the circadian drive to sleep. 
Process C and Process S collectively create a feeling of sleepiness at the end of each day 
(elevated sleep drive and elevated melatonin levels). Once sleep is initiated the drive to 
sleep (Process S) decreases. Process S will continue to decrease throughout the sleep 
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period until Process C initiates wakefulness starting Process S over again (Rusterholz et 
al., 2010).  
The sleep – wake cycle is defined as a 24 hour period where approximately 16 
hours are devoted to wakefulness and approximately 8 hours are devoted to sleep 
(Rosenberg & Doghramji, 2011). The term “circadian” refers to processes that occur in 
24 hour period intervals. Circadian rhythms control many behaviors (e.g., sleep-wake, 
feeding), physiological functions (e.g., body temperature, blood pressure) and endocrine 
functions (corticosterone concentration) on a rhythmic 24 hour diurnal cycle (Kalsbeek et 
al., 2011). The circadian rhythms are influenced by an internal clock that is controlled by 
a pacemaker located in two clusters of nerve cells called the suprachiasmatic nuclei 
(SCN). The SCN is located in an area at the base of the brain called the anterior 
hypothalamus (Pail et al., 2011).  This pacemaker is at the heart of the promotion of 
wakefulness during the day and sleep at night.  
The natural inclination to sleep or sleep propensity function is comprised of three 
components that take place over a 24 hour period. Hilton (2002) identifies the three 
components as curves. These curves are used to describe sleep propensity function. The 
first curve takes place in the mid-afternoon. At this time, the body has an episode of high-
sleep propensity and experiences sleepiness. The second curve, also known as the 
“forbidden zone”, takes place in the early evening. At this time there is a low propensity 
for sleep and this period lasts approximately 2 to 3 hours. The third curve is the last curve 
and refers to the nocturnal sleep gate. This occurs late in the evening and during this time 
there is a steep rise in sleepiness (Hilton, 2002).  
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Light is the primary stimulus for coordinating the circadian system with the sleep-
wake cycle (Schmidt, Chen, & Hattar, 2011). The cycle of light and dark intervals play 
the most important role in regulating the sleep – wake cycle and the circadian rhythm. 
Under normal light – dark conditions the human circadian system is synchronized with 
the geophysical day. The synchronous resetting of the circadian system is continuous, 
resetting every day. Even under circumstances when the cycle is delayed, or lengthened 
for example, by an hour, the delay remains at one hour due to the body’s ability to reset 
itself day after day (Marhefka, 2011). As noted earlier, light is vital to the sleep – wake 
cycle. Limited or absent light adversely affects the sleep – wake cycle. This reduction in 
exposure can result from decreased sensitivity to light by the retina or to decreased 
exposure to light due to lifestyle.  
Body temperature is a physiological circadian rhythm that is intricately related to 
the sleep process. Thermoregulation is the maintenance of a rather steady body 
temperature even under a variety of external conditions. About one to one and a half 
hours before falling sleep, the body starts to lose heat from its central core; this decrease 
in temperature brings on increased feelings of tiredness in normal healthy adults. These 
physiological changes happen well before going to bed and may occur without the 
person’s awareness. The body achieves this temperature drop by shifting heat from the 
core of the body to the periphery of the body (Bach et al., 2011).  
Sleep – related changes in body temperature and the effects of environmental 
temperature on sleep suggest that sleep regulation and body temperature are related. 
Evidence of this involves the preoptic area (POA) of the brain, specifically the medial 
preoptic area (mPOA), which participates in both the regulation of sleep and body 
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temperature (Kumar, 2004). The mPOA controls sleep and temperature through 
independent, but overlapping neuronal circuits (Kumar, 2004). The mPOA is located in a 
region of the hypothalamus between the anterior commissure and the optic chiasm. The 
anterior commissure is a round bundle of nerve fibers that crosses the midline of the brain 
near the anterior limit of the third ventricle. The optic chiasm is the part of the brain 
where the optic nerves partially cross, allowing for the parts of the right eye seeing things 
on the right side to be connected to the left side of the brain, and vice versa (Kidd, 2011).  
Endocrine events, as previously mentioned, occur as a circadian rhythm. 
Melatonin, a small molecule produced in the pineal gland, is strongly linked to the sleep 
wake cycle. The pineal gland is considered part of the diencephalon, and sits near the 
base of the third ventricle, in approximately the anatomic center of the brain. Melatonin is 
synthesized from tryptophan, undergoes oxidation to serotonin, and is eventually 
converted to its active form (Paredes et al., 2009). Production and secretion of melatonin 
also follow a circadian pattern. As daylight approaches, light perceived by the retina is 
encoded and then sent to the pineal gland. Light serves to suppress the pineal activity, 
resulting in a decrease in melatonin levels, which remain low until secretion is once again 
stimulated by the onset of darkness (Borjigin, Zhang, & Calinescu, 2011).  Melatonin 
levels closely correlate with sleep propensity. Melatonin secretion is at its highest level 
during high sleep propensity and is noticeably decreased during episodes of low sleep 
propensity. 
Effects of disrupted sleep.  The effect of sleep and sleeplessness-related 
problems has gained attention over the past several years. This may be in part due to the 
effect sleep has on the physiological function of the human brain (Couyoumdjian et al., 
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2010). One particular area of the brain thought to be affected by sleep and sleeplessness 
is the prefrontal cortex (PFC). Ingvar (1979) studied PFC over 30 years ago and found 
that this area of the brain demonstrated a high metabolic rate even during periods of 
resting wakefulness. The frontal cortex is responsible for numerous thought processes 
including visual and auditory discrimination, task switching, semantics, and problem 
solving (Duncan & Owen, 2000) and is thought to receive much needed recovery during 
sleep (De Gennaro et al., 2007).  Furthermore, Duncan and Owen (2000) assert that the 
PFC is the hardest working cortical area of the brain during wakefulness. Lim, Tan, 
Parimal, Dinges, and Chee (2010) conducted a study involving 23 participants comparing 
their ability to complete a selective attention task after a night of normal sleep and after a 
night of sleep deprivation (awake overnight). Each participant was asked to identify two 
different pictures by pressing a button when select images appeared. When this test was 
completed during the rested state (after a night of normal sleep) the participants 
accurately identified the pictures with high hit rates (M = 91, 11.0%). After sleep 
deprivation, a significant decline in hit rates was observed (M = 4, 4.6%). The authors 
concluded that sleep deprivation resulted in reduced visual selectivity.   
Kim, Kim, Park, Choi, and Lee (2011) conducted a study involving 58 residents 
and interns and examined the effect disrupted sleep has on physical health, work 
performance, and cognition. The participants were divided into three groups: severe sleep 
deprived (S-SD, average less than 4 hours of sleep per night), mild-moderate sleep 
deprived (M-SD, 4-6 hours of sleep per night), and non-sleep deprived (Non-SD, more 
than 6 hours of sleep per night). The S-SD group had significantly higher Epworth 
Sleepiness Scale (ESS) scores than the M-SD and Non-SD groups (p < 0.05) as well as 
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higher levels of stress, more frequent attention deficit, and more difficulty learning (p < 
0.05). The primary physical health complaint was related to the specific work 
environment, such as standing or sitting all day. Participants reported sleep deprivation as 
having a negative impact on their social activities as well as experiencing difficulty in 
learning and concentration.  
Behavioral challenges such as shift work also affect the sleep pattern and cause 
disrupted sleep. Shift work forces the person to be awake during the time when the 
circadian rhythm is promoting sleep, and likewise, attempting to sleep when the body is 
normally promoting wakefulness. This generally results in a reduction in the number of 
hours an individual is able to sleep during a 24 hour period. The misalignment in the 
sleep schedule can impair both sleep and waking alertness. The sleep loss that results 
from this disruption leads to an increase in the sleep drive during the hours in which work 
is required, thus resulting in impaired alertness (Kolla & Auger, 2011).  
Jet lag is another example of a behavior influenced by the circadian rhythm. 
When individuals cross several time zones, there is a significant variation in sleep and 
wake times and the circadian system is altered. The result is a temporary misalignment in 
the new sleep/wake schedule that can lead to sleep disruption. The person attempts sleep 
during a time that wakefulness is being promoted and awakens when sleep is actively 
being promoted (Saksvik et al., 2011).  
Obstructive Sleep Apnea Syndrome 
Prevalence 
 Obstructive sleep apnea syndrome is characterized by repetitive episodes of 
complete or partial obstructions of the upper airway during sleep (Lurie, 2011). 
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Obstructive sleep apnea is a common sleep disorder in the United States. Data extracted 
from the Wisconsin Sleep Cohort found that state employees between ages 30 and 60 had 
a prevalence of 9 percent in women and 24 percent in men when OSA was defined by an 
AHI > 5 events per hour during sleep. However, when OSA was more strictly defined as 
a syndrome (i.e., OSAS) which includes both AHI > 5 and significant self-reported 
sleepiness, the prevalence was lower (women 2 percent, men 4 percent) (Young et al., 
2008). Prevalence rates have been found to be similar to the Wisconsin Sleep Cohort 
prevalence in other diverse populations. Ip et al. (2004) conducted a community study 
involving middle aged Chinese women and found a prevalence rate of 2.1 percent.  
 Udwadia, Doshi, Lonkar, and Singh (2004) found a 7.5 percent prevalence rate in middle 
aged Indian men. The authors of one study measuring the prevalence of OSAS in 
commercial drivers found that approximately 28 percent of commercial drivers in the 
United States suffered from at least a mild form of OSAS (AHI > 5) (Pack, Dinges, & 
Maislin, 2002). Somers et al. (2008) suggest that as many as 85 percent of people with 
clinically significant OSAS are undiagnosed.  
 Despite the agreement between population-based studies, the true prevalence of 
OSAS is not easily estimated given the lack of clarity with cut-off measures 
distinguishing normal breathing during sleep from sleep disordered breathing (Kapur, 
2010). The issue is primarily related to the definition of hypopnea. The American 
Academy of Sleep Medicine scoring manual provides two acceptable definitions for 
hypopnea: 1) >30 percent decline in nasal-pressure-transducer-signal (measurement of 
nasal airflow) excursions with a 4 percent desaturation from pre-event baseline, and 2) a 
>50 percent decline in nasal-pressure-transducer-signal excursions with a >3 percent 
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desaturation from baseline or arousal (Iber, Ancoli-Israel, Chesson, & Quan, 2007). A 
great deal of variance can occur with the use of different diagnostic criteria. For example, 
in the Sleep Heart Health Study the median AHI was almost 3–fold higher and the 
prevalence of moderate to severe OSAS was 2–fold higher when hypopneas with >3 
percent desaturation or arousals were scored than when a >4 percent oxygen desaturation 
was required for hypopnea scoring (Redline et al., 2000).  
 The cut off for number of apneas / hypopneas per hour of sleep has traditionally 
been set at greater than or equal to 5 events per hour. However, not all evidence supports 
the use of this value. For example, in the Wisconsin Sleep Cohort (n= 709) the authors 
examined the association between sleep-disordered breathing and hypertension and found 
that participants with AHI values between 0.1 and 4.9 events per hour had 1.4 times the 
risk of developing hypertension when compared to participants with AHI of zero 
(Peppard et al., 2000). Additionally, researchers from the Sleep Heart Health Study 
examined the prevalence of sleepiness in the moderate to severe OSAS population and 
found that only 46 percent of the 6,440 participants with AHI > 15 (moderate to severe) 
reported excessive daytime sleepiness (Baldwin et al., 2010).  The above results provide 
evidence that OSAS can lead to negative health outcomes at all levels of disease severity 
and that clinical significance can occur in any form of the disease based on individual 
susceptibility.  
Pathophysiology of Obstructive Sleep Apnea Syndrome  
 The physiology of sleep is significantly impaired in the OSAS patient. In 
individuals without OSAS, wakefulness brings about an increase in cardiac vagal tone, 
resulting in an increase in the metabolic rate and an increase in the activity of the 
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sympathetic nervous system, resulting in micro-arousals (rapid changes in alertness) and 
an increase in blood pressure and heart rate. The opposite is true during times of normal 
sleep where there are decreases in cardiac vagal tone, metabolic rate, and sympathetic 
nervous system activity that all contribute to decreases in blood pressure and heart rate 
(Fava, Montagnana, Favaloro, Guidi, & Lippi, 2011).  
Repeated bouts of wakefulness during sleep that are characteristic of OSAS 
patients are due to the repeated episodes of intermittent hypoxia and hypercapnia that 
occur in an attempt to surmount the pharyngeal obstacle. These episodes result in changes 
in pulmonary volume, intrathoracic pressure, and micro-arousals (Kario, 2009). After 
these hypoxia / hypercapnia events, OSAS patients demonstrate oscillations in 
hemodynamic parameters throughout the night. Heart rate, blood pressure, and cardiac 
output fluctuate constantly as a result of the repeated respiratory events and the rapid 
changes in alertness due to micro-arousals (Fava et al., 2011). Repeated arousals also 
result in less time spent in deep sleep (i.e., stages 3 and 4) among the OSAS population 
(Loureiro, Drummond, Winck, & Almeida, 2009; Sukegawa et al., 2009). Treatment of 
OSAS with CPAP has shown to decrease hypoxia - hypercapnia episodes (Garcia, 
Sharafkhaneh, Kirshkowitz, Elkhatib, & Sharafkhaneh, 2011; Lee & McNicholas, 2011), 
intrathoracic pressure (Kario, 2009) and micro-arousals (Sukegawa et al., 2009). 
Factors Associated with Obstructive Sleep Apnea Syndrome 
 OSAS is a complex, multifactorial disease. Researchers have alluded to numerous 
associated factors. Epidemiological factors that are well documented to be associated 
with increased risk of developing OSAS are obesity, gender, and age. The following 
section will provide an overview of metabolic syndrome, obesity, craniofacial 
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morphology, gender, age, and race and the association each has with the pathogenesis of 
OSAS.  
Metabolic Syndrome  
 The prevalence of metabolic syndrome is higher among OSAS patients. A 
diagnosis of metabolic syndrome is based on the occurrence of at least three out of five 
components of the syndrome. The components include elevated levels of plasma glucose 
(or previously diagnosed type 2 diabetes), elevated triglycerides, decreased HDL 
cholesterol, abdominal obesity (increased waist circumference), and increased arterial 
blood pressure (Kumor et al., 2013). Ambrosetti et al. (2006) examined 89 patients with 
OSAS and found metabolic syndrome in 53 percent of the cases. The link between OSAS 
and metabolic syndrome has been well established in the literature. Vgontzas, Bixler, and 
Chrousos (2005) reported that patients with OSAS had significantly higher fasting 
glucose and insulin levels compared to weight matched control subjects. Furthermore, 
Gruber, Horwood, Sithole, Ali, and Idris (2006) examined 38 subjects with OSAS and 41 
controls and found that OSAS patients were nearly six times as likely to have metabolic 
syndrome as the control group.  
 It is plausible that metabolic syndrome and OSAS exert negative synergistic 
consequences on the cardiovascular system (Bonsignore & Zito, 2008; Levy et al., 2009). 
Su et al. (2013) reported that factors such as higher fasting blood glucose and body mass 
index (BMI) and lower high-density lipoprotein (HDL) cholesterol were more strongly 
associated with elevated cardiovascular disease than with OSAS. This finding suggests 
that metabolic parameters are important contributors to cardiovascular diseases and 
should be corrected in patients with OSAS. Sharma, Agrawal, and Damodaran (2011) 
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conducted a double-blind placebo-controlled trial in OSAS patients and found that blood 
pressure was lowered and metabolic abnormalities were partially reversed with three 
months of CPAP therapy.  
 There is increasing literature to support a causal relationship between OSAS and 
metabolic syndrome. The intermittent hypoxia that occurs with OSAS may induce or 
exacerbate metabolic syndrome. Additional clinical evidence is needed to identify direct 
and indirect associations between OSAS and metabolic syndrome, because such evidence 
could improve the understanding and management of both disorders (Zamarron, 
Cuadrado, & Alvarez-Sala, 2013).  
Obesity 
 Researchers involved in the Sleep Heart Health Study assert that there is a 
relationship between rising BMI to increasing OSAS severity (Young, et al., 2002). The 
2007-2008 prevalence of obesity among adult men was 32.2 percent and among adult 
women was 35.5 percent (Flegal, Carroll, Ogden, & Curtin, 2010). The term overweight 
refers to an individual who weighs more than a standard weight for height and age, 
whereas the term obesity is a much more complex term that refers to excessive body fat 
that places an individual at an increased risk for multiple health problems (Yu & Berger, 
2011). Increased body weight above a standard level has been identified in epidemiologic 
studies from around the world as the strongest risk factor for OSAS (Punjabi, 2008). 
Obesity is defined as a body mass index (BMI, weight in kilograms divided by height in 
meters), of more than 27 kg/m
2
 (Partinen & Hublin, 2005).  
As noted previously in regard to metabolic syndrome, obesity also can be 
considered a consequence of OSAS.  Anandam, Akinnusi, Kufel, Porhomayon, and El-
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Solh (2011) reported a meta-analysis of nine articles that included data from patients 
experiencing both pre- and post- dietary weight loss PSG’s where an AHI was obtained. 
The researchers found that the OSAS cure rate dropped from 61 percent at 3 months to 
less than 10 percent at one year. This was hypothesized to potentially be due to the 
challenge of maintaining large amounts of weight loss. Specifically, one of the studies 
reviewed by Anandam et al. was a study of 23 patients with various degrees of obesity 
(Pasquali et al., 1990). Only 30 percent of the participants were able to maintain a weight 
loss of greater than 10 percent after a two-year weight reduction program, and all AHI 
improvements were lost by the end of the study. Sampol et al. (1998) examined the 
efficacy of long term dietary weight loss and OSAS and found that after 5 years, 46 
percent of those studied were not able to maintain a one half drop in BMI following 
dietary weight loss. Likewise, Greenburg, Lettieri, and Eliasson (2009) found that even 
when weight loss surgery resulted in dramatic weight loss, only 25 percent of patients 
achieved resolution of their OSAS. This suggests that weight loss is not curative in all 
cases of OSAS with significant weight loss. More importantly, the meta-analysis 
concludes that weight loss programs should not be considered curative of OSAS, but 
rather as an adjunct to other OSAS treatment. There are limited data available examining 
the effect of modest weight loss on OSAS, and additional studies are needed to examine 
the large number of patients who have residual OSAS following dietary weight loss.  
Obesity affects breathing in several different ways, including alterations in the 
geometrical structure of the upper airway, increased collapsibility of the upper airway, or 
by exacerbating OSAS occurrences due to obesity related reductions in decreased 
residual capacity and increased whole – body oxygen demand (Yu & Berger, 2011). 
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Evidence does suggest, however, that weight loss can reduce the severity of OSAS and 
may be curative in isolated cases (Epstein et al., 2009; Fritscher, Mottin, Canani, & 
Chatkin, 2007). Researchers from the Wisconsin Sleep Cohort identified weight change 
as a significant determinant of disease progression or regression and evidence supports 
more severe OSAS in association with obesity in some adults. Participants with a 10 
percent increase in weight demonstrated a 32 percent increase in AHI as well as a six fold 
risk of developing moderate to severe OSAS. Furthermore, participants with a decrease 
of 10 percent in weight demonstrated a decrease of 26 percent in AHI scores (Peppard et 
al., 2000). The association between body weight and OSAS has also been corroborated 
by the by researchers in the Cleveland Family Study, which confirmed that body weight, 
gender, and age (discussed below) were independent determinants in the incidence of 
OSAS (Tishler, Larkin, Schluchter, & Redline, 2003). A rigorous meta-analysis 
conducted by Anandam et al. (2011) found that weight loss is insufficient to eliminate 
OSAS and that the traditional approach of recommending weight loss as a first line of 
treatment is likely to be ineffective as well as very difficult to achieve due to hormonal 
disruption. Weight loss tends to normalize AHI rather than eliminate apneas in the 
majority of patients who are able to lose weight. In addition, the hormonal factors 
associated with OSAS can make it extremely difficult for people with OSAS to lose 
weight and maintain that loss if the OSAS is not treated with other interventions. The 
American Society of Sleep Medicine recommends CPAP as the first line of treatment for 
all cases of adult OSAS (Epstein et al., 2009). 
Patients with a neck circumference greater than 40 cm tend to have a more 
collapsible airway during wakefulness (Tsai, Ho, Lee, & Tan, 2009). Inspiration and 
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airflow create negative pressure that can lead to airway collapse. The musculature 
surrounding the palate, pharynx, and tongue help to maintain airway patency and an 
increase in the load on the muscles can produce changes in the airway configuration and 
can alter the function of the airway. Fat deposits around the airway can potentially 
narrow the pharynx, changing the shape and mechanical properties, resulting in an 
increased risk for OSAS (Sutherland, Lee, & Cistulli, 2012). Hora et al. (2007) examined 
thirty-seven obese males with OSAS and fourteen obese control males and found that 
OSAS patients had statistically significant  higher BMI, neck circumference, and waist 
circumference than the control group (p< 0.05). An additional study of 109 subjects (76 
men, 33 women) was conducted and the authors revealed that BMI and neck 
circumference significantly increased the severity of OSAS in both men and women (p < 
0.001, p = 0.013, respectively) (Tsai et al., 2009). Martinho et al. (2008) examined the 
head and neck measurements of 45 severely obese patients in order to determine if upper 
airway and facial skeleton was related to the severity of OSAS. A large neck 
circumference (p = 0.02), the presence of a voluminous lateral airway wall (p = 0.04), an 
anatomically posterior soft palate (p = 0.03), and a thick soft palate (p = 0.04) were all 
directly associated with the severity of OSAS. These data may mean that a thicker neck is 
a predictive factor for OSAS.  
 Consistent with the previous discussion about obesity and OSA, increased waist 
circumference is thought to play an integral role in sleep related disorders, specifically 
OSAS (Simpson et al., 2010). An increased waist circumference is defined by a measure 
of greater than 102 cm in men and 88 cm in women. The result of the additional weight 
combined with increased waist circumference is thought to displace the diaphragm, 
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leading to a decrease in tracheal traction on the upper airway, thereby resulting in an 
increased risk for upper airway collapse (Stadler, McEvoy, Bradley, Paul, & Catcheside, 
2010). A study conducted by Angelico et al. (2010) of 281 subjects identified an 
independent association between OSAS severity and waist circumference (t =3.93, p= 
0.000). Any degree of excess body weight should be viewed as a potential risk factor or 
indicator of existing OSAS.  
Craniofacial Morphology  
 While obesity is the primary risk factor for OSAS, craniofacial morphology is a 
major contributing factor.  Several characteristics to be considered are skeletal 
morphology related to the hyoid and head position, mandible, maxilla, and cranial base. 
Soft tissue morphology of the upper airway is also considered a risk factor (Sutherland et 
al., 2011). The inferior displacement of the hyoid bone is thought to contribute to the 
pathogenesis of OSAS (Johal, Patel, & Battagel, 2007). Pressure exerted from excess 
pharyngeal tissues in the upper airway may contribute to a lower position of the hyoid 
bone in apneic patients due to the fact that when hyoid position between subjects (55 
apneic and 55 non-apneic) was examined no difference was noted once tongue size was 
controlled (Chi, et al., 2011). Cephalometric studies (measurements of the head) 
indicated that OSAS patients have a smaller cranial base angle. Albajalan, Samsudin, and 
Hassan (2011) examined 25 OSAS patients and 25 non-OSAS patients and found that 
airway spaces were narrower (upper, middle, and lower), hyoid bone position was more 
posterior and inferior, and the angle of the cranial base was more acute in the OSAS 
group than the non-OSAS group suggesting a relationship between hyoid position and 
cranial base angle with the pathogenesis of OSAS.  
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The skeletal morphology of the maxilla and mandible are also contributing factors 
to the pathogenesis of OSAS, specifically a short maxilla and a narrow maxillary arch 
(Schendel et al., 2011). Chi et al. (2011) found that when comparing apneic and non-
apneic patients (25 apneic, 25 non-apneic), the male apneic patients presented with 
shorter mandibles. There was no significant difference in the female participants in this 
study. In addition to skeletal morphology, soft tissue morphology should also be 
considered as a contributing factor to the pathogenesis of OSAS. Johal et al. (2007) 
examined the skeletal and soft tissue anatomy of 99 OSAS patients and 99 non-OSAS 
patients. The researcher’s results support the known existing evidence related to hyoid 
bone position and maxilla and mandibular size. The researchers also found that tongue 
size was increased (p = 0.021) as well as soft palate area, length, and thickness (p = 
0.001) for those with OSAS.  
Gender Differences in Obstructive Sleep Apnea Syndrome  
 For decades the male gender has demonstrated a higher prevalence for OSAS than 
the female gender (Block, 1979; Guilleminault, Van den, & Milter, 1978; Guilleminault, 
Quera-Salva, Partinen, & Jamieson, 1988). This is a direct result of the fact that all early 
studies of OSAS included men only. It was not until 1993 (Young et al., 1993) that 
females were included in a general population study of OSAS. Since this seminal study, 
gender differences in OSAS have been further refined. For example, men experience 
OSAS at two to three times the rate of women (Young et al., 1993), are diagnosed at a 
younger age (Young et al., 1997), and have a higher apnea-hypopnea index (AHI) than 
women (Shepertycky, Banno, & Kryger, 2005). Gender differences are in part, due to 
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differences in risk factors. The following section delineates the risk factors for both males 
and females.  
There are several gender differences that suggest why men are more prone to 
obstructive sleep apnea than women. The male predisposition for OSAS has been 
attributed to sex differences in anatomical and functional properties of the upper airway, 
hormones, and respiratory control stability (Lin, Davidson, & Ancoli-Israel, 2008). 
Respiratory stability is determined by gas-exchange efficiency, circulatory delays to 
central and peripheral chemoreceptors, and chemo responsiveness (Wellman et al., 2003).   
 The “Great Leap Forward” hypothesis postulates that evolutionary changes in the 
upper respiratory tract predispose man to obstructive sleep apnea. The hypothesis 
suggests that the same anatomic features that support our ability to speak are the very 
same features that place our airway in jeopardy as we sleep and are more likely to occur 
in men than women (Davidson, 2003; Davidson, Sedgh, Tran, & Sepnowsky, 2005). The 
hypothesis asserts that the combination of laryngeal descent, shortening of the oral cavity 
and soft palate, and a tongue that resides partially in the pharynx can obstruct respiration 
during sleep (Davidson et al., 2005). Laryngeal descent elongates the oropharynx by 
reshaping the airway. Airway reshaping results in a slight separation of the epiglottis and 
the soft palate which in turn leads to the lengthening of the oropharynx. This elongation 
allows the tongue to collapse during sleep. While laryngeal descent does occur in both 
males and females during infancy it is the occurrence during puberty in males that 
predisposes men to OSAS (Lin et al., 2008).   
 Malhorta et al. (2002) found that when compared to women, men had a longer 
pharyngeal airway, an increased soft palate, and an increased pharyngeal volume. A 
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longer susceptible airway (hard palate to epiglottis) increases the propensity for airway 
collapse. During inspiration the extent of airway collapse is greater in men than women 
due to anatomic differences (Malhorta et al., 2002). Sawnani et al. (2010) supports the 
earlier study by Malhorta et al. (2002) asserting that the increased length of the 
oropharynx in the male airway is what leads to a greater risk of collapse during sleep 
(Sawnani et al., 2010).  
 The contribution of hormones to risk for OSAS is obscure due to the fact that the 
literature supports both elevated testosterone levels as well as decreased estrogen and 
progesterone levels (Behan & Wenninger, 2008; Lin et al., 2008; Myers & Meacham, 
2003). Testosterone is thought to play a key role in the development of OSAS; however 
the mechanism of that relationship is unclear. The hypoxic ventilatory drive has been 
observed to increase with the administration of testosterone which may in turn contribute 
to OSAS (Myers & Meacham, 2003). This occurs in the following manner: ventilation is 
driven by increased carbon dioxide levels in the blood, testosterone is thought to lead to 
an increase in sensitivity to low oxygen levels; thus lowering carbon dioxide levels. 
Lowering carbon dioxide levels during sleep may possibly lead to periods of apnea 
(Hanafy, 2007).  
 Cistulli, Grunstein, and Sullivan (1994) found that testosterone leads to an 
increase in upper airway collapsibility as well as a possible link to a decrease in the 
dimensions of the upper airway.  However, a more recent study conducted by Liu et al. 
(2003) did not support changes in the upper airway as specifically testosterone related. 
Liu et al. (2003) found that testosterone reduced total sleep time by approximately one 
hour, increased the duration of hypoxemia by approximately 5 minutes per night, and 
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disrupted breathing during sleep by approximately seven events per hour in healthy men 
over 60 years. Although the exact mechanism of testosterone and its interference with 
sleep is still disputed, the well-established male preponderance of sleep apnea does 
suggest that testosterone is somehow linked and therefore additional studies are needed to 
further evaluate the association between OSAS and testosterone levels.  
 Although many population studies support male predominance of OSAS, there is 
evidence that suggests women in the menopause transition have an increased risk of the 
disease (Anttalainen et al., 2006; Hachul et al., 2010; Kapsimalis & Kryger, 2009; Resta 
et al., 2003). Menopause lessens the excretion of estrogen and progesterone and is 
thought to contribute to the development of OSAS among women (Lin et al., 2008). Over 
30 years ago evidence revealed that progesterone played a pivotal role in the mediation of 
respiratory stimulation, suggesting that progesterone was partially responsible for 
protecting females from OSAS and increasing the prevalence of OSAS among men 
(Skatrud, Dempsey, & Kaiser, 1978; Zwillich, Natalino, Sutton, & Weil, 1978).  
  The first robust data reported linking the menopause transition to OSAS was 
conducted by Young, Finn, Austin, and Peterson (2003) who examined 589 women to 
evaluate the effect menopause has on sleep disordered breathing (i.e. OSAS). Results 
revealed that postmenopausal women were 2.6 times more likely to have an AHI greater 
than 5 and 3.5 times more likely to have an AHI greater than 15 than their premenopausal 
counterparts. Hachul et al. (2010) examined a group of 931 women who sought treatment 
for a sleep complaint in an effort to study how the menstrual cycle affected sleep patterns. 
The researchers found that women taking hormonal contraceptives reported less snoring 
and had fewer arousals than women not taking hormonal contraceptives. In addition, the 
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researchers found that women taking hormone replacement therapy experienced less total 
awake time when compared to participants not taking hormone replacement therapy. 
Lastly, the researchers of this study suggest that menopausal women are more likely to 
demonstrate an apnea-hypopnea index greater than 5 events per hour. Interestingly, the 
researchers also found that women with a regular menstrual cycle reported less difficulty 
with sleep when compared to their irregular menstrual cycle counterparts. This finding 
supports a report of the data provided from the 2007 National Sleep Foundation annual 
Sleep in America Poll by Kapsimalis and Kryger (2009). This poll included 1,254 women 
in the United States who were polled by telephone and asked questions related to snoring, 
witnessed apneas, obesity, hypertension, and daytime sleepiness as well as questions 
related to general sleep habits, sleep problems, medical disorders, and menstrual cycle 
status. The report by Kapsimalis and Kryger (2009) concluded that women with regular 
menstrual cycles had a 16 percent risk for OSAS compared to 23 percent risk for women 
with irregular menstrual cycles.  
 Hachul et al. (2008) studied 33 postmenopausal women in an effort to examine 
the effects of estrogen and progesterone on sleep. Participants were randomly assigned to 
an estrogen or placebo group. After 12 weeks of receiving either the estrogen or placebo 
and while still taking the estrogen or placebo, all participants received progesterone for 
12 weeks. The estrogen plus progesterone was more effective than the estrogen alone in 
decreasing several nighttime factors measured in the study such as, bruxism (11.1 percent 
vs. 0 percent), periodic limb movements (8.1 percent vs. 2.8 percent), and hot flashes 
(14.2 percent vs. 0 percent). The most significant finding the researchers of this study 
found for the present study is that once the progesterone therapy was added to the groups 
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both groups demonstrated a decrease in breathing irregularities and arousals from sleep, 
suggesting that progesterone has a protective effect against OSAS.  
Age 
 Sleep – related difficulties become more common with advanced age (Berry & 
Foster, 2005; Malhorta et al., 2006; Punjabi, 2008). Although the underlying mechanisms 
are not quite clear it has been hypothesized that changes in pharyngeal collapsibility, 
ventilatory control stability, and possibly arousal responses are responsible for the 
increase of OSAS with age (Eikermann et al., 2007). The ventilatory control system is 
somewhat stable in the elderly, suggesting that ventilatory stability is not a probable 
cause of the increase in OSAS in this population (Wellman et al., 2007). However, 
pharyngeal collapsibility and arousal from sleep at the cessation of an apnea or a 
hypopnea do appear to play a role in the development of OSAS (Oliven, Aspandiarov, 
Gankin, Gaitini, & Tov, 2008; Thurnheer, Wraith, & Douglas, 2001). The increase in 
pharyngeal collapsibility has been attributed to an increase in airway length (women), an 
increase in the size of parapharyngeal fat pads, a decrease in the negative pressure reflex 
(reflex responsible for maintaining a patent upper airway), and an anatomical change in 
the bony shape of the pharynx (lower anteroposterior to lateral dimension ratio, 
indicating a more lateral skeleton and an increase in the length of the soft palate) 
(Malhorta et al., 2006).  
Racial Differences in Sleep and Obstructive Sleep Apnea Syndrome  
Several authors suggest that there may be important racial differences related to 
sleep disturbances (Fiorentino, Marler, Stepnowsky, Johnson, & Ancoli-Israel, 2006; 
Profant, Ancoli-Israel, & Dimsdale, 2002; Redline et al., 1998). African Americans spend 
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a smaller portion of time in deep sleep, or slow wave sleep, and spend more time in the 
light stages of sleep (stages 1 and 2) (Beatty et al., 2011; Hall et al., 2009; Mezick et al., 
2008; Ruiter, DeCoster, Jacobs, & Lichstein, 2011). Redline et al. (1998) found that 
African Americans had a twofold higher risk for OSAS, a higher mean respiratory 
disturbance index, greater difficulty initiating sleep, reduced sleep satisfaction, and 
reported taking more naps than Caucasians. Tomfohr, Ancoli-Israel, Loredo, and  
Dimsdale  (2011) conducted a study of 64 African Americans and 99 Caucasian 
Americans to investigate the differences in sleep architecture (i.e., sleep efficiency, total 
sleep time, sleep latency, time awake after sleep onset, time spent in various stages of 
sleep). The authors found that African Americans took longer to fall asleep, slept more in 
stage 2, and  spent less time in slow wave deep sleep than did their Caucasian American 
counterparts. 
Studies investigating racial differences in sleep apnea and OSAS are somewhat 
conflicting. Data involving African - Americans suggest that the prevalence of sleep 
apnea is equal to or higher than Caucasian counterparts and that sleep apnea may be more 
severe in this population (Durrence & Lichstein, 2006; Yaggi & Strohl, 2010).  Ancoli-
Israel et al. (1995) found that when compared to Caucasians (n=346), African Americans 
(n=54) had similar prevalence of OSAS (30 percent, 32 percent respectively) but a more 
severe form of the disease with 17 percent of the African Americans having an AHI 
greater than 30 compared to 8 percent of the Caucasians. Friedman et al. (2006) found 
that African Americans have a higher rate of daytime sleepiness and snoring when 
compared to Caucasian Americans.  Ralls and Grigg-Damberger (2012) suggest that 
although there does seem to be a higher prevalence and severity in OSAS in African 
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Americans than Caucasian Americans, these differences may be due to environmental 
factors such as lower socioeconomic status and living in disadvantaged neighborhoods. 
Further research is needed to definitely determine the contribution of race to prevalence 
of sleep apnea and OSAS.  
Complications Related to Obstructive Sleep Apnea Syndrome 
The literature suggests that OSAS contributes to the evolution of health 
complications largely through excessive stimulation of the sympathetic nervous system 
(SNS). In medically uncompromised individuals, SNS activity (i.e., platelet aggregation, 
blood pressure, heart rate, metabolic rate) decreases during sleep. The opposite occurs 
with the OSAS patient due to recurrent respiratory events (apneas and hypopneas) and 
periods of alertness (micro-arousals) (Fava et al., 2011; Tazbirek, Slowinska, Kawalski, 
& Pierzchala, 2011). The result of the apneas and hypopneas is hypoxia (oxygen 
deficiency) and hypercapnia (increase in carbon dioxide), which in conjunction with the 
effects of excessive SNS activation, can lead to cardiovascular disease as well as EDS.   
Cardiovascular Disease 
It is unclear if OSAS is an independent risk factor for cardiovascular disease. 
There is, however, evidence of a well-established association with different types of 
cardiovascular disease including heart failure, hypertension, and stroke. Cigarette 
smoking is also an important factor to consider given the established relationship between 
cigarette smoking and cardiovascular disease (Lavie & Lavie, 2008).  
Cigarette smoking. Cigarette smoking is linked to oxidative stress, and as a 
result is considered a risk factor for cardiovascular disease (Lavie & Lavie, 2008). A 
number of studies have identified an association between OSAS and underlying 
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predisposing factors to cardiovascular disease (Lavie, 2003; Lavie, Vishnevsky, & Lavie, 
2004; Yamauchi et al., 2005). Lavie and Lavie (2008) compared 35 sleep apnea patients 
who smoke with 35 sleep apnea patients who do not smoke to investigate oxidative stress 
and inflammatory markers, important risk factors for cardiovascular disease. The authors 
found that OSAS patients who smoke 20 cigarettes or more a day for a period of 5 or 
more years have higher levels of oxidative stress and inflammatory markers and 
therefore, have a higher risk of cardiovascular disease than those who do not smoke.  
Heart failure. Estimates are that 11 to 37 percent of patients with heart failure 
have moderate to severe OSAS (Wang et al., 2007). Obstructive respiratory events lead to 
significant temporary cardiovascular disturbances that may possibly lead to long-term 
cardiovascular remodeling. For example, the increase in negative intrathoracic pressure 
as a result of inspiratory efforts against an occluded airway increases venous return 
resulting in an enlarged right ventricle, which subsequently leads to slowed left 
ventricular filling and a decrease in stroke volume (Fava et al., 2011).  It is also 
hypothesized that the intermittent hypoxia associated with OSAS may result in a 
disturbance between oxygen supply and demand, resulting in cardiac ischemia (Fava et 
al., 2011; Gami, Howard, Olson, & Somers, 2005; Schneider et al., 2000).  
Kepez et al. (2011) conducted a study of 97 patients being evaluated for OSAS 
and found that as the severity of the OSAS disease progressed so did patient risk for 
coronary disease. The participants were grouped according to AHI scores (simple 
snoring, mild OSAS, moderate OSAS, severe OSAS) and coronary risk was assessed by 
tomographic calcium scoring (quantification of arterial calcification).The risk linearly 
increased from the simple snorers group to the severe OSAS group (Kepez et al., 2011).   
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Mechanical factors are considered in research examining the association between 
OSAS and cardiovascular risk.  Left ventricular remodeling is thought to occur in OSAS 
patients as a result of oxidative stress as well as the effects of intrathoracic pressure 
(Kohler & Stradling, 2010; Singh, Patial, Vijayan, & Ravi, 2009). Kohler and Stradling 
(2010) assert that the increase in intrathoracic pressure results in an increase in the 
workload of the heart due to changes in venous return. Singh et al. (2009) sought to 
identify the effect of an anti-oxidant treatment to improve OSAS. Twenty male patients 
underwent PSG for diagnosis of OSAS and subsequently received two nights of CPAP 
therapy. Following the two nights of CPAP therapy the participants took an oral dose of 
the anti-oxidants vitamin C and vitamin E for 45 days. After 45 days of anti-oxidant 
treatment the participants underwent another PSG. The results revealed a decrease in the 
number of apneic events, more sleep time spent in stages 3 and 4, and a decrease in 
Epworth Sleepiness Scale scores.  
Wang et al. (2007) found a relationship between untreated OSAS and mortality 
rates. The 164 heart failure patients who underwent PSG were grouped as follows: mild 
to no sleep apnea (n=113) (AHI < 15 per hour of sleep), untreated OSAS (n=37) (AHI > 
15 per hour of sleep), and CPAP treated OSAS (n=14). Participants were followed up 
during a mean period of 2.9 and a maximum period of 7.3 years. Participants with 
untreated OSAS had a significantly higher rate of mortality than the participants with 
mild to no sleep apnea. The untreated OSAS group, 9 (24 percent) participants died. Five 
of the 9 were from sudden death, 1 from a myocardial infarction, and 3 from progressive 
heart failure. In the mild to no sleep apnea group, 14 (12 percent) participants died. Five 
died from sudden death, 3 from myocardial infarctions, and 6 from progressive heart 
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failure. There were no deaths in the treated OSAS group (Wang et al., 2007). The results 
from this study suggest that patients with heart failure and untreated OSAS have an 
increased risk of death regardless of the OSAS severity.  It is important to note that it is 
possible that other factors, which could not be controlled for, might explain these 
differences.  
Hypertension.  
OSAS is an accepted cause of hypertension and is recognized as such by both 
European and American recommendations on hypertension (Baguet et al., 2009; Mansia 
et al., 2007). The primary mechanism behind the association between hypertension and 
OSAS is the increase in sympathetic activity during the apnea periods. Elevated 
sympathetic activity results in an increase in peripheral arterial resistance leading to an 
increase in diastolic pressure. Apneic patients develop cardiovascular sensitivity to the 
repetitive sympathetic stimulation and the blood pressure response to the CPAP depends 
on the severity of the OSAS, the more severe the disease the more effective the treatment 
(Baguet et al., 2009). The Joint National Committee on the prevention, detection, 
evaluation, and treatment of high blood pressure (JNC7) classifies blood pressure as 
follows: optimal (normotensive) blood pressure is a systolic blood pressure less than 120 
mmHg and a diastolic blood pressure less than 80 mmHg, prehypertension is a systolic 
blood pressure between 120 and 139 mmHg and diastolic blood pressure between 80 and 
89 mmHg, a systolic blood pressure above 140 mmHg and / or a diastolic blood pressure 
over 90 is classified as hypertension. Hypertension is further divided into stage 1 (systolic 
between 140-159 mmHg), stage 2 (systolic between 160-179 mmHg, stage 3 (systolic 
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between 180-209 mmHg), and stage 4 (systolic greater than 210 mmHg) (Mancia et al., 
2013; Miller & Jehn, 2004).   
Peppard et al. (2000) conducted a prospective longitudinal evaluation to examine 
the association between objective measures of OSAS and hypertension (at least 140/90) 
or the use of antihypertensive medications over a decade ago. The study consisted of 709 
participants that were evaluated at baseline and at a four year follow-up. Of the 709, 184 
were followed for an additional four years, and reevaluated at 8 years. The researchers 
found that persons with few events of apnea or hypopnea (0.1 to 4.9 events per hour) at 
baseline were 42 percent more likely to have hypertension at follow-up than those with 
no events of apnea or hypopnea. Persons experiencing 5.0 to 14.9 events of apnea or 
hypopnea per hour were two times more likely to have hypertension at follow-up and 
those with apnea or hypopnea events of 15 or more an hour were three times more likely 
to have hypertension at follow-up. The authors of this early study suggest that OSAS in 
any form is a risk factor for hypertension.  
 Jaimchariyatam et al. (2010) conducted the first study comparing cardiovascular 
outcomes in the mild OSAS population. The study included 255 participants diagnosed 
with mild OSAS between 2004 and 2006. The participants were divided into two groups, 
CPAP (n = 93) and no CPAP (n = 162). At the end of the 2 year period the CPAP group 
had a 1.97 point reduction in mean blood pressure and the non CPAP group had a 9.61 
point elevation in mean blood pressure. Ozeke et al. (2011) examined the influence of 
OSAS disease severity on nocturnal heart rate and hypertension. There were a total of 
540 participants in the study by Ozeke et al. (2011), 166 mild OSAS patients (42 females, 
124 males), 147 moderate OSAS patients (25 females, 122 males), and 227 severe OSAS 
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patients (25 females, 202 males). Group comparison regarding severity of OSAS and 
nocturnal mean HR was significant for both females and males (p>0.001), maximal heart 
rate (p=0.004 in females; p=0.003 in males), hypertension (p=0.026 in females; p<0.001 
in males), as well as systolic (p=0.004 in females; p<0.001 in males) and diastolic (p=NS 
in females; p<0.001 in males) blood pressure. Based on the evidence, hypertension 
should be explored in all apneic patients, regardless of disease severity.  
Stroke. Recent data suggest that OSAS is associated with ischemic stroke 
(Somers et al., 2008). The physiological response to OSAS (i.e. blood pressure surges, 
increased sympathetic nervous system stimulation, hypoxia, and hypercapnia) is thought 
to increase stroke in OSAS patients. Redline et al. (2010) examined the prevalence of 
stroke among OSAS patients in a community based sample. A total of 5,422 participants 
were included in the study. The participants had no history of stroke and were identified 
as having OSAS (baseline PSG between 1995 and 1998) but were not being treated with 
pressure therapy. Participants were followed for 8.7 years, during which time a total of 
193 strokes occurred (85 in men and 108 in women). Compared to men with low apnea 
hypopnea index scores, men with moderately severe OSAS had nearly a threefold 
increased risk of stroke.  In the mild to moderate range (AHI - 5-25) the risk of stroke 
increased by 6 percent with each one unit increase in the AHI. There was no significant 
association between stroke and AHI in women.  
 The increased risk of stroke among patients with OSAS might be related to 
carotid artery thickness. Thirty men with severe OSAS (AHI >20) were included in a 
study conducted by Altin et al. (2005). All carotid arteries were found to be significantly 
thicker in participants with severe OSAS when compared to those with mild OSAS. 
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Severe OSAS participants also had more carotid plaque (thickening of at least 1.2 mm) 
than their mild OSAS counterparts, as well as more plague localizations.  The 
relationship between plaque formation and OSAS is not fully understood. However, one 
author of a dated experimental study found a direct relationship between degenerative 
changes of the arterial walls and oxygen desaturations (Gainer, 1987).   
Excessive Daytime Sleepiness 
 Excessive daytime sleepiness (EDS) affects an estimated 20 percent of adults in 
the United States and is the leading symptom reported by patients presenting to sleep 
clinics (Pagel, 2009). EDS refers to the tendency to fall asleep while involved in activities 
that are not stimulating, such as listening to a speaker or watching television. However, 
many individuals experiencing EDS are at risk for falling asleep at more inopportune 
times, such as while driving or working.  Individuals experiencing EDS are at higher risk 
of motor vehicle accidents, work- related incidents, and overall poorer health than those 
individuals not experiencing EDS (Chen, Vorona, Chiu, & Ware, 2008; Drake et al., 
2010; Gooneratne et al., 2003).  
A common problem encountered when a patient reports excessive sleepiness is 
distinguishing between sleepiness and fatigue. Sleepiness and fatigue are conceptually 
distinguishable but are continually confounded in research, research measurement 
instruments, health care settings, and in everyday spoken language. Sleepiness is 
generally described as a feeling associated with an overwhelming need to sleep and is 
associated with terms such as drowsy or somnolent. Fatigue, on the other hand, is related 
more to a feeling of the need to rest rather than sleep and descriptive terms such as 
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lethargy, listlessness, and exhaustion have been used to describe feelings of fatigue (Neu, 
Linkowski, & Bon, 2010).   
EDS is prevalent among those with sleep disorders, particularly narcolepsy and 
OSAS. When addressing healthcare concerns related to sleep, the typical clinical 
interview involves the assessment of EDS, not fatigue. EDS can occur secondary to a 
number of things including side effects of medications, sleep deprivation, substance use, 
OSAS,  circadian rhythm disorders, sleep – related movement disorders, psychiatric 
conditions (i.e., depression), and medical conditions (i.e., stroke, cancer, head trauma). 
EDS can also exist as a primary hypersomnia (i.e., idiopathic hypersomnia, narcolepsy). 
However, it should be noted that EDS of primary origin is far less common and a 
secondary origin should be considered initially (Pagel, 2009).  
There are several assessment tools available to determine the severity of EDS. 
These include, but are not limited to, the Epworth Sleepiness Scale (ESS), the Stanford 
Sleepiness Scale (SSS), and the Multiple Sleep Latency Test (MSLT). The ESS and SSS 
both measure subjective daytime sleepiness while the MSLT measures objective daytime 
sleepiness. The ESS was used in this study and was developed in 1991 by Johns (Johns, 
1991). The intent of the ESS is to differentiate alert individuals from those with excessive 
daytime sleepiness. The ESS presents eight various situations in which an individual self-
scores (0-3) how likely they are to fall asleep in each situation, with a score of greater 
than ten suggesting significant daytime sleepiness (Johns, 1991).  
Drake et al. (2010) conducted a study of 618 persons to determine the risk 
associated with sleepiness and motor vehicle accidents. The participants were divided 
into 3 groups based on sleepiness (excessively sleepy, n = 69; moderately sleepy, n = 
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204; alert, n = 345). Over a 10 year period the excessively sleepy group was found to be 
at a significant increase for motor vehicle accidents when compared to the moderately 
sleepy and alert groups. The positive linear relationship between the prevalence of motor 
vehicle crashes and physiological sleepiness was significant (p < 0.05) which supports 
EDS as a predictive factor in motor vehicle accidents. The relationship between 
commercial bus drivers and level of sleepiness has also been researched. Vennelle, 
Engleman, and Douglas (2010) examined 677 Epworth Sleepiness Scale (ESS) 
questionnaires completed by commercial bus drivers. Of the 677, 133 (20 percent) 
reported ESS scores > 10 (indicating excessive daytime sleepiness). Additional data 
obtained includes 8 percent reporting that they had fallen asleep at the wheel at least 
once, 7 percent reported having an accident due to sleepiness, and 18 percent reported a 
near miss accident as a result of sleepiness. 
EDS has been associated with professional performance in physicians and judges. 
Chen et al. (2008) conducted a study of physicians and sleepiness. The study yielded 180 
completed surveys. Of the 180, 41 had ESS scores of 11 or greater. The survey included 
numerous questions related to how sleepiness affected professional practice. When asked 
the following statement, “My work is unaffected by sleep loss and fatigue.” Eighty-one 
percent disagreed or strongly disagreed. Additionally, 48 percent had worried about 
having a car accident on the way home post-call and 24 percent had made medical errors 
because of sleep loss and fatigue. Grunstein and Banerjee (2007) reviewed 15 judicial 
cases involving sleepiness and professional performance by judges. In 10 of the cases a 
retrial was ordered and in five of the cases there was either a dismissal of the case or 
retirement of the judge.  
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Sleep related problems are increasingly being recognized as a contributing factor 
to heightened pain perception, increased morbidity and mortality, as well as a decrease in 
overall quality of life (Taylor-Gjevre, Gjevre, Nair, Skomro, & Lim, 2011). A study 
conducted by Sforza, de Saint Hilaire, Pelissolo, Rochat, and Ibanez (2002) included 60 
participants, 16 snorers and 44 with diagnosed OSAS. The purpose of the study was to 
evaluate the impact, if any, daytime sleepiness had on mood disorders. Anxiety was 
present in 16 percent of participants and depression was present in 7 percent of 
participants. The mean ESS score during the day was 10.9 with 29 participants having 
ESS greater than 11. Participants with a higher degree of subjective sleep propensity and 
daytime sleepiness were found to be at an increased risk for depression as evidenced by 
higher Hospital Anxiety (HAD-A) and Depression (HAD-D) Scale scores.  
Continuous Positive Airway Pressure Treatment for Excessive Daytime Sleepiness 
Continuous positive airway pressure (CPAP) is an effective method of treatment 
for individuals experiencing EDS. Avlonitou, Kapsimalis, Varouchakis, Vardavas, and 
Behrakis (2011) assessed the quality of life and symptoms in patients with OSAS after 
beginning CPAP therapy and adhering for 6 months to the regimen. A total of 50 patients 
(9 women, 41 men) underwent PSG, were diagnosed with OSAS, and prescribed CPAP 
therapy for treatment. Quality of life, as measured by the Sleep Apnea Quality of Life 
index (SAQLI), was significantly improved following 6 months adherence to CPAP 
therapy (total SAQLI scores -3.8 + 0.9 before CPAP, 5.8 + 0.8 after CPAP, p < 0.01). 
Other constructs of the SAQLI also demonstrated improvement; daily functioning (4.2 + 
1.4 before CPAP, 6.0 + 0.9 after CPAP, p <0.01), social interactions (4.8 + 1.3 before 
CPAP, 6.3 + 0.7, p < 0.01), emotional functioning (4.4 + 1.4 before CPAP, 5.7 + 1.0, p 
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<0.01) and symptoms (1.6 + 0.8 before CPAP, 5.8 + 1.2, p < 0.01). Overall ESS scores 
were decreased (13.7 + 6.5 before CPAP, 3.9 + 3.8 after CPAP, p < 0.01). The results of 
this study may provide evidence that adherence to CPAP therapy improves quality of life 
and decreases daytime sleepiness.  
Excessive daytime sleepiness (EDS) is a primary symptom of, and a well-
recognized consequence of OSAS (Rosenberg & Doghramji, 2009; Seneviratne & 
Puvanendran, 2004). While it is not unexpected for many people to fall asleep during 
boring situations it may be even more difficult for people with OSAS to remain awake 
even during times that demand sustained vigilance and concentration. EDS is exacerbated 
and more prominent in OSAS sufferers during times that would not normally evoke 
sleepiness in individuals without OSAS (Rosenberg & Doghramji, 2009). Patel et al. 
(2003) compiled the results of a meta-analysis regarding the effect of CPAP use on 
subjective and objective sleepiness. The most significant finding was that the more severe 
the OSAS, the more decrease in daytime sleepiness an individual experienced with 
CPAP.  
Continuous Positive Airway Pressure. Continuous positive airway pressure 
(CPAP) is the primary treatment for OSAS.  Nasal CPAP was first developed as a 
treatment for OSAS in 1981 (Sullivan, Berthon-Jones, Issa & Eves, 1981), but was not 
widely accepted until 1985 (Grunstein, 2005). The most significant effect of CPAP on the 
upper airway is that it acts as a pneumatic splint to prevent airway collapse during sleep 
by providing continuous pressure to the airway. The result is an increase in the actual size 
of the airway during treatment, primarily in the lateral direction, as well as decreasing 
lateral pharyngeal wall thickness and reducing airway edema associated with chronic 
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vibration (snoring) and airway occlusion (Yagi et al., 2009). CPAP therapy is not curative 
and should be expected as a lifetime treatment.  
  Currently there are three forms of positive airway pressure devices available: 1) 
continuous positive airway pressure (CPAP); 2) bilevel positive airway pressure 
(BiPAP); and 3) automatic self-adjusting positive airway pressure (APAP). CPAP uses a 
facial mask, or some other means of interface (such as intra-nasal tubes) with the upper 
airway, that is connected to an air pump that generates pressure in the airway while also 
allowing for the release of expired carbon dioxide. Therapeutic supplements can also be 
used with CPAP, such as oxygen for patients whose oxygen levels do not normalize and 
humidification to make use more comfortable by reducing the tendency of CPAP to cause 
nasal dryness (Chang, Cox, & Shaffer, 2011). The most common method of air pressure 
delivery is with a nasal mask, which is normally manufactured in standard sizes, 
however, some companies offer custom fitting for patients that present with unusual 
facial contours. Generally, the construction of the nasal masks consists of an outer shell 
of hard plastic with a soft inner seal constructed of rubber or rubber filled with silicone 
gel. One major variation of CPAP pressure delivery is nasal prongs, which enter the 
nostril and form a seal around the opening of the nostril (Haba-Rubio et al., 2011).  
 The first pressure generating devices for CPAP treatment were air compressors, 
which although effective, were considered by patients to be bulky and noisy. An advance 
in the CPAP delivery technology came with the replacement of air compressors with air 
blowers. Advantages of air blowers include smaller size, greatly reduced noise, and their 
ability to compensate for a loss of mask pressure due to an imperfect seal with the face 
(McNicholas, 2002). Due to the fact that inspiration and expiration are conducted through 
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the same nasal mask, it is necessary to provide a means for the removal of expired carbon 
dioxide. Common ways of dealing with this problem are to place a small hole in the mask 
or to attach a valve to the mask, which serves to remove expiratory flow from the system 
(Cistulli & Grunstein, 2005). 
 There are some variations in the pressure delivery of CPAP blower systems. 
Patients often find exhalation more difficult than inhalation on CPAP because they must 
exhale against the airflow. The first method of modified pressure delivery designed to 
address this problem was bi-level positive airway pressure (BiPAP). The BiPAP system 
allows for inspiratory and expiratory air pressure levels to be adjusted independently, and 
was designed to make the positive airway pressure more tolerable (Blau et al., 2011). 
This means of pressure delivery allows for a higher pressure level to be set for inspiration 
(inspiratory positive airway pressure), without equivalent high pressure for expiration 
(expiratory positive airway pressure) and the greater discomfort that this might cause. 
 The newest variation on pressure delivery is automatic CPAP (APAP), which 
delivers varying amounts of pressure throughout the night according to the amount 
required to eliminate snoring and sleep apnea. This system was developed in part due to 
issues surrounding the determination of what the ideal pressure for an individual would 
be throughout the entire night, in various sleeping positions and in various stages of sleep 
(McArdle et al., 2010). A specific range of CPAP pressures is set for the APAP device, 
with the lowest pressure being utilized at the beginning of any sleep period. The major 
theoretical advantage of APAP is increased patient comfort, because only the amount of 
pressure that is needed at any given point in the sleep period is delivered. APAP may be 
particularly useful in patients that are intolerant of higher pressures or in patients in 
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whom the ideal pressure is highly variable (McArdle et al., 2010). It is possible to also 
benefit economically with the APAP due to less technician time, the elimination of in-
hospital polysomnography, and potentially reducing the number of clinic visits of patients 
with CPAP adherence issues (Grunstein, 2005; McArdle et al., 2010).  
The use of CPAP therapy in patients with severe OSAS (apnea hypopnea index 
>30) has been studied for decades and has demonstrated reversal of upper airway 
obstruction during sleep as well as reducing the most notable consequence of OSAS, 
daytime sleepiness. The use of BiPAP and APAP is increasing. Marrone et al. (2011) 
found that when compared to CPAP, APAP was equally as effective at decreasing blood 
pressure during wakefulness and sleep. Reeves-Hoche et al. (1995) compared 36 CPAP 
patients and 26 BiPAP patients to determine if the use of BiPAP would result in an 
increase in the number of hours of use. The authors did not find a significant increase in 
the amount of time the device was used (80 percent CPAP; 82 percent BiPAP). Weber, 
Kellner, Burbach, Kirchheiner, and Ruhle (1995) studied the effect of CPAP and BiPAP 
on cardiac output and did not find a significant difference in hemodynamics between the    
two forms of positive pressure. Additional studies are needed to evaluate the 
effectiveness of APAP and BiPAP on hypertension and EDS.  
The literature reviewed for this paper includes studies examining the use of 
CPAP. Two examples of early studies related to objective daytime sleepiness with 
moderate to severe OSAS were identified. Engleman, Martin, Deary, and Douglas (1994) 
examined 32 patients with OSAS and Engleman et al. (1999) examined 23 patients with 
OSAS. The researchers of each study found a decrease in objective daytime sleepiness 
with CPAP use. It should be noted that each study found improvement in daytime 
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sleepiness with less than ideal nightly use (3.4 hours per night, 3.2 hours per night). Two 
early studies examining subjective daytime sleepiness with moderate to severe OSAS 
were also reviewed. Hardinge, Pitson, and Stradling (1995) examined two groups, one (n 
= 50) at 2 months after the initiation of CPAP therapy and another (n = 25) at 1 year after 
initiation of CPAP therapy. Both groups demonstrated a decrease in ESS scores 
indicating a decrease in subjective daytime sleepiness. Ballester et al. (1999) conducted a 
study involving 105 participants in two groups, conservative treatment (n = 37) (complete 
enough hours of sleep each night, sleep on their side, lose weight by following a home 
diet prescribed by a dietician, and avoiding the use of sedatives and alcohol consumption) 
and CPAP group (n = 68) (CPAP therapy in addition to all criteria for conservative 
group). The authors found that the relief of sleepiness was greater in the group that used 
CPAP therapy in conjunction with conservative measures than in the conservative 
treatment group alone. Montserrat et al. (2001) conducted a study involving 48 patients 
comparing CPAP therapy to a placebo therapy (sham CPAP). The authors found that 
CPAP therapy was significantly more effective in reducing daytime sleepiness than the 
sham CPAP therapy. An earlier study conducted by Kingshott et al. (2000) examined 62 
patients with moderate to severe OSAS and found a significant improvement in daytime 
function after 6 months of CPAP treatment. More recently Antic et al. (2011) examined 
174 moderate to severe OSAS patients. The authors identified a greater achievement of 
overall daytime function with longer nightly CPAP use. A study by Machado et al. 
(2010) involving moderate to severe OSAS patients with coexisting chronic obstructive 
pulmonary disease (COPD) receiving long term oxygen therapy was reviewed. In this 
particular study 95 patients with moderate to severe OSAS and COPD were examined. Of 
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the 95, 61 were treated with CPAP therapy and 34 were not treated with CPAP therapy. 
The results of this study found 5 – year survival rate estimates of 71 and 26 percent, 
respectively. Therefore, based on these findings supporting the use of CPAP with 
moderate to severe OSAS, it can be concluded that CPAP is an effective choice of 
treatment with this population.  
 The effect of CPAP treatment in patients with mild OSAS severity has not been as 
well established as that of moderate to severe severity. Four studies were reviewed 
involving the use of CPAP with mild OSAS. Engleman et al. (1997) conducted a placebo 
controlled study involving 16 patients with mild OSAS. The participants received four 
weeks of placebo therapy and four weeks of CPAP therapy. Participants receiving CPAP 
therapy demonstrated an increase in cognitive performance and a decrease in 
psychological distress. However, it should be noted that Epworth Sleepiness Scale (ESS) 
scores for CPAP therapy did not reflect significant reduction in subjective daytime 
sleepiness when compared to the placebo therapy. The small sample size might explain 
the lack of statistical significance.  
Engleman et al. (1999) conducted a second, larger study (n = 34) similar to the 
study previously discussed. Participants received CPAP therapy for four weeks and an 
oral placebo therapy for four weeks. CPAP therapy, when compared to placebo therapy, 
revealed a decrease in subjective daytime sleepiness as evidenced by a decrease in ESS 
scores. On the other hand, objective daytime sleepiness, as measured by the Maintenance 
Wakefulness Test, was not reduced. The researchers of this study support the use of 
CPAP therapy with mild OSAS but they also suggest that not all patients’ sleepiness in 
this population will improve with CPAP therapy. 
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 Monasterio et al. (2001) compared the effectiveness of CPAP therapy plus 
conservative therapy to conservative therapy alone in 125 mild OSAS patients (59 
conservative therapy alone, 66 CPAP plus conservative therapy). Conservative therapy 
consisted of following a home diet plan for weight loss in individuals having a BMI 
greater than 27, avoidance of alcohol or sedative consumption, avoidance of the supine 
position for sleeping, and an acceptable number of hours of sleep per night. The authors 
did not find a significant benefit for CPAP therapy plus conservative therapy over 
conservative alone. ESS scores did improve slightly, but did not reach the level of 
significance. The authors did reveal an improvement in OSAS related symptoms 
(snoring, nocturia, concentration difficulties, breathing pauses, morning headache, 
morning drowsiness, and nonrestorative sleep), which suggests that CPAP therapy may 
have a role in the treatment of mild OSAS.   
Barnes et al. (2002) studied 42 patients with mild to moderate OSAS over an 8 
week trial period in which participants used CPAP for four weeks and took an oral 
placebo tablet for four weeks. Although self-reported symptoms of sleep quality were 
improved with CPAP, neither objective nor subjective symptoms showed improvement 
with CPAP over the oral placebo tablet.  Based on the results of the above studies 
additional research is needed to validate the use of CPAP therapy in patients with mild 
OSAS.  
Continuous positive airway pressure adherence. Despite the effectiveness of 
CPAP in the treatment of OSAS, treatment efficacy is limited by the lack of adherence to 
the prescribed therapy. Adherence is defined as 4 hours or greater of nightly use 70 
percent of the nights (Grunstein, 2005; Weaver & Grunstein, 2008). The minimum 
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therapeutic usage of CPAP has been debated in the literature. Engleman et al. (1994) 
found a decrease in daytime sleepiness and improved cognitive function with as little as 3 
hours of nightly use. Additional researchers have yielded results that suggest that a 
decrease in subjective sleepiness, objective sleepiness, memory, and daily functioning 
can be achieved at various levels of usage, ranging from 4 hours of nightly use to 7.5 
hours of nightly use (Stradling & Davies, 2000; Weaver et al., 2007; Zimmerman, 
Arnedt, Stanchina, Millman, & Aloia, 2006). Despite the abundance of studies related to 
CPAP therapy use, the dose-response relationship between CPAP adherence and sleep 
apnea severity is not fully understood. Therefore, the minimum amount of nightly use has 
not been established (Stepnowsky & Dimsdale, 2002).  Weaver et al. (2007) asserts that 
some individuals might have variation in the need for CPAP therapy. This suggests that 
individuals with shorter nightly use may be effectively treated with CPAP, particularly 
with respect to sleepiness. Furthermore, Weaver and Grunstein (2008) assert that the 
clinical evidence available, albeit variable, suggest that any use is better than no use. 
Despite the known variation related to dose-response, the arbitrary cut point of at least 4 
hours per night 70 percent of the nights has become the standard usage to define 
adherence.  
Estimates are that approximately 50 percent of patients prescribed CPAP therapy 
are nonadherent one year post prescription (Ballard, Gay, & Strollo, 2007) and that non-
adherence rates are as high as 29 – 83 percent (Weaver & Grunstein, 2008). Several 
factors have been identified as possible causes of nonadherence including; 1) cost of 
CPAP therapy; 2) mask interface (discomfort); 3) nasal congestion; 4) difficulty adapting 
to the pressure; 5) social context (marital status and employment) (Beecroft, Zanon, 
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Lukie, & Hanly, 2003; Chasens, Pack, Maislin, Dinges, & Weaver, 2005; Gagnadoux et 
al., 2011); and 6) lack of personal involvement in care (Rodgers, 2014). These factors 
will be described further below.  
 CPAP therapy, when compared to the costs associated with untreated OSAS, is 
cost effective (Tzischinsky, Shahrabani, & Peled, 2011).  Simon-Tuval et al. (2009) 
conducted a study involving 162 newly diagnosed OSAS patients that were prescribed 
CPAP therapy and found that only 40 percent of the patients purchased their CPAP 
machine. Of the 162 patients, 76 percent stated that the device was too expensive. 
Socioeconomic status plays a pivotal role in adherence to CPAP therapy. Insurance 
coverage related to CPAP treatment may vary considerably by insurance carrier, and 
studies demonstrate that non-adherence is higher in individuals with insufficient health 
coverage (Simon-Tuval et al., 2009; Tzischinsky et al., 2011). 
 Finding the most appropriate mask interface is a major challenge for many CPAP 
patients. There are a variety of interfaces available; nasal, oronasal (full face), and total 
face masks. Mask technology has improved greatly, and this is vital since mask 
discomfort remains a critical influence on adherence. An inappropriate mask fit can lead 
to air leaks, which appear to be the primary force behind mask discomfort. The air leaks 
can cause a drop in positive pressure, leading to sleep interruption as well as persistent 
OSAS. In addition, a poorly fitting mask can lead to facial bruising and possibly 
ulceration on the bridge of the nose (Grunstein, 2005). Despite the availability of various 
mask interfaces there remains a gap in the literature comparing the different mask types. 
However, it does appear that the newly developed mask interfaces are associated with 
fewer issues related to mask fit (Grunstein, 2005). For those patients who continue to 
54 
 
 
 
have mask-fit problems, despite the newly designed masks available, a change in mask 
interface may be necessary to improve fit and ultimately improve adherence. The nasal 
mask involves the use of nasal prongs and may be a solution for some patients. However, 
the use of nasal prongs does not come without problems as well and have been associated 
with nasal irritation and dryness of the mouth and throat (Ruhle & Nilius, 2008). 
 Nasal stuffiness is a commonly associated side effect of CPAP therapy (Weaver 
& Grunstein, 2008). Existing data available related to nasal congestion and CPAP therapy 
is somewhat limited in so far as it only addresses the fact that it occurs in this patient 
population. A few dated studies were identified and reviewed. Hayes, McGregor, 
Roberts, Schroter, and Pride (1995) found that mask mouth air leak was a factor in the 
nasal symptoms that many CPAP users experienced, however allergic conditions may 
also play a role. Data suggest that nearly all patients experience nasal stuffiness initially, 
and as many as 10 percent will continue to experience such symptoms after 6 months of 
treatment (Pepin et al., 1995). There are a number of potential reasons for the nasal 
stuffiness associated with CPAP therapy. It is possible that CPAP causes mucous 
production due to the pressure on the mucosal receptors, which may also lead to the 
reported side effect of significant nasal dryness (Grunstein, 2005). Another plausible 
explanation is that the CPAP treatment itself causes allergic reactions in some patients. 
Patients should also be screened for nasal polyps or a deviated septum, which could also 
contribute to the nasal symptoms (Grunstein, 2005). One of the primary treatments for 
the associated nasal stuffiness is heated humidification of the air within the device. The 
humidified air aids in the prevention of nasal dryness as well as nasal stuffiness. 
Koutsourelakis et al. (2011) conducted a study involving 25 patients receiving CPAP 
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treatment for OSAS and found that the relative humidity within the device was not 
significantly decreased when using heated humidification, even when a mouth leak 
occurred. Furthermore, it was discovered that when heated humidification was added to 
the face mask interface there was no decrease in the relative humidity at all, resulting in 
less nasal dryness and nasal congestion. Patients may also benefit from antihistamines or 
saline nasal sprays (Koutsourelakis et al., 2011).  
 Adapting to the pressure of the CPAP device can be challenging for some 
patients. However, there is little evidence that suggests that air pressure directly relates to 
low adherence rates (Grunstein, 2005). It has been reported that some patients will 
complain of too much pressure in the nose or difficulty resisting the pressure on 
exhalation. For this population of patients it is possible that a ramp feature might be 
helpful. A ramp feature is a delay timer that can be added to the CPAP system. The timer 
allows for the desired pressure to be reached gradually, thus reducing the resistance on 
exhalation. There is no evidence that use of the ramp feature actually increases adherence 
rates; however, most patients prefer using this feature to avoid the delivery of the 
therapeutic pressure all at once (McNicholas, 2002). An early study conducted by 
Pressman, Peterson, Meyer, Harkins, and Gurijala (1995) examined overuse of the ramp 
feature and found that “ramp abuse” can lead to under treatment of OSAS. It is therefore 
imperative that patients receive adequate education involving use of the ramp feature.  
Bi-level pressure is another feature that can assist with the difficulty experienced 
by some patients during exhalation. As mentioned previously, BiPAP allows for the 
inspiratory and expiratory pressures to be set independently. The underlying principle is 
that the expiratory pressure setting can be lowered, thus reducing the difficulty with 
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expiration. Early studies indicate however, that BiPAP may be less effective in 
maintaining the upper airway patency than CPAP (Gugger & Vock, 1992; Sanders & 
Kern, 1990). The authors of these early studies suggest that BiPAP should not be a first 
line therapy, and should be considered only for those patients that have extreme difficulty 
adjusting to standard CPAP.  
The social context of daily life should be taken into account when screening 
patients for CPAP adherence. Gagnadoux et al. (2011) conducted a study involving 1,141 
patients prescribed CPAP for nightly use for at least 90 days. The researchers sought to 
examine the impact of socioeconomic factors, as well as patients and disease 
characteristics prior to the initiation of CPAP therapy, on long term adherence. The 
researchers found that marital status and employment status are associated with CPAP 
adherence. Patients living alone and / or working are at a greater risk for non-adherence 
than their married and retired counterparts. Relationship quality is also a factor to be 
considered when exploring non-adherence. Baron, Smith, Czajkowski, Gunn, and Jones 
(2009) examined relationship quality and CPAP adherence in 42 married males. They 
found that patients with higher levels of relationship conflict were less likely to adhere to 
CPAP therapy and averaged lower nightly adherence rates over the first 3 months of 
treatment than those with lower levels of relationship conflict.  
Lewis, Seale, Bartle, Watkins, and Ebden (2004) sought to identify factors 
associated with non-adherence prior to the initiation of CPAP therapy in a group 80 
patients. The authors found that patients living alone used CPAP an average of 3.2 hours 
a night during the first week of treatment, whereas patients living with a partner averaged 
4.5 hours a night. Cartwright (2008) examined the sleep of 10 married couples to 
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determine how CPAP adherence was affected by sleeping with a partner. This author 
asserted that adherence is strongly related to the bed partner’s sensitivity to arousal 
related to the CPAP apparatus and that assessing and addressing the partner’s response to 
the treatment may improve treatment adherence. Marital status is related to higher levels 
of CPAP adherence and should be considered when evaluating patients for adherence.  
Lack of personal involvement in the management of OSAS potentially reduces 
adherence to CPAP therapy. Rodgers (2014) conducted a grounded theory study 
involving 82 adults who were at various stages in the process of being diagnosed and 
living with OSAS. The researcher sought to examine the experiences of adults who live 
with the condition.  Rodgers found that participants expressed a desire to be more 
involved in the management of their care, particularly at the onset of disease management 
with positive airway pressure machine selection and delivery interface. Participants also 
reported the desire to be able to monitor their own therapy. Based on the findings, 
Rodgers suggests that CPAP adherence rates may be increased by involving the patients 
in their care and placing an emphasis on self-management.  
Adherence monitoring. Early efforts at objective monitoring of adherence with 
CPAP were built-in timers that actually provided information related to when the 
machine was switched on. This time was referred to as “machine-on” time (Collard et al., 
1997). However, there was no way to determine whether the mask was being worn during 
the time that the machine was on. The ability to differentiate between “machine-on” time 
and the amount of time the mask was actually worn, referred to as “mask-on face” time, 
was achieved with the advent of the new CPAP machines. This is accomplished with 
built-in pressure transducers that are able to detect variations in pressure; therefore a 
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significant drop in pressure indicates that the mask is not being worn. In addition, CPAP 
machines are equipped with an electronic memory card that records the aforementioned 
information. Patients are instructed to bring the memory card with them to either the 
physician’s office or the medical supply company. If the information is supplied to the 
medical supply company it will be forwarded to the physician prior to the patient’s follow 
up visit.  This information allows the clinician to assess both how many hours the 
machine was functioning as well as how many hours the mask was worn (Cistulli & 
Grunstein, 2005). 
Theoretical Framework 
The researcher of this study is concerned with the effect CPAP use has on 
daytime sleepiness and blood pressure in persons with mild OSAS. Daytime sleepiness 
and elevated blood pressure can have both psychological and physiological antecedents 
and sequela and can interact with one another.  In order to adequately support the 
psychological component of daytime sleepiness and the physiological component of 
blood pressure a synthesized model approach was taken. Daytime sleepiness is routinely 
assessed in the clinical setting as a subjective complaint. Bebee and Gozal’s prefrontal 
cortex model of the effects of OSAS (Figure 1) was modified for the current study. The 
modified theoretical model presented in figure 2 illustrates both physiological and 
psychological changes that occur as a result of OSAS and the impact CPAP use has on 
each. CPAP use will be divided into two categories, use four or more hours nightly 70 
percent of the nights and use less than four hours nightly 70 percent of the nights. The cut 
point of at least four hours of nightly use 70 percent of nights has been used in numerous 
research studies (Aloia, Arnedt, Stepnowsky, Hecht, & Borrelli,  2005; Bachour & 
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Maasilta, 2004; Chasens et al., 2005; Lindberg, Berne, Elmasry, Hedner, & Janson, 
2006).  
There is a preponderance of evidence indicating that untreated OSAS leads to 
physiological changes in the cardiovascular system that can result in hypertension 
(Buchner et al., 2007; Jaimchariyatam et al., 2010; Laaban et al., 2010; Peppard et al., 
2000). The primary mechanism behind the association between hypertension and OSAS 
is the increase in sympathetic activity during the periods of apnea. Elevated sympathetic 
activity results in an increase in peripheral arterial resistance leading to an increase in 
diastolic pressure. CPAP use decreases sympathetic activity resulting in a decrease in 
blood pressure (Penzel et al., 2012). As indicated in figure 2, when CPAP is used four or 
more hours a night 70 percent of the nights, there is a reduction in sympathetic activity 
resulting in a decrease in blood pressure (Weaver & Grunstein, 2008). When CPAP is 
used less than four hours a night 70 percent of the nights the clinical benefits are not as 
great. Loube et al. (1999) and Arias at al. (2008) found significant reductions in systolic 
and diastolic blood pressure (p = 0.001 and p = 0.006, respectively) when patients used 
the CPAP device for greater than four hours a night. Dorkova, Petrasova, Molcanyiova, 
Popovnakova, and Tkacova (2008) and Jelic et al. (2008) found that patients who used 
the CPAP device less than four hours a night did not experience reductions in systolic or 
diastolic blood pressure. Faccenda, Mackay, Boon, and Douglas (2001) also found a 
greater reduction in blood pressure with greater CPAP use. 
 EDS is a common finding in persons with OSAS (Tomfohr et al., 2011). The 
literature suggests that CPAP use can reduce associated daytime symptoms (Avlonitou et 
al., 2011). Figure 2 illustrates how mild OSAS leads to sleep disruption that then leads to 
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adverse daytime effects such as excessive daytime sleepiness. Avlonitou et al. (2011) 
conducted a study involving 50 OSAS patients in all degrees of disease severity (mild n = 
8, moderate n = 8, and severe n = 34) and found a significant decrease (p = 0.001) in 
excessive daytime sleepiness where CPAP use was defined as at least four hours of 
nightly use 70 percent of the nights per week. Weaver et al. (2007) found that four hours 
of nightly use improved daytime sleepiness as measured by the Epworth Sleepiness Scale 
and increased the likelihood that normal levels of sleepiness could be achieved. Donadio 
et al. (2007) examined 10 newly diagnosed OSAS patients with EDS and found a 
consistent decrease in daytime sleepiness with CPAP use of six hours (+ 3) per night. It 
can be concluded from the previous literature that CPAP use of four or more hours 
nightly for 70 percent of the nights leads to a decrease in daytime sleepiness. As the 
feedback loop illustrates for both physiological and psychological components, less than 
four hours of CPAP use can lead to progression of the disease which in turn can lead to 
an increase in blood pressure and an increase in daytime sleepiness.  
Beebe and Gozal Theoretical Model  
Beebe and Gozal theorized that the disruption in sleep within the context of 
OSAS prevents restorative sleep from occurring. This is in part due to the intermittent 
hypoxemia and hypercarbia that occur as a result of OSAS. They further assert that in 
addition to the blood gas abnormalities and sleep disruption that occurs a chemical and 
structural central nervous system cellular injury takes place as well, leading to a 
dysfunction of the prefrontal regions of the brain cortex (PFC). The dysfunction in the 
PFC is manifested behaviorally in what has been termed by neuropsychologists as 
executive dysfunction.  Executive dysfunction is theorized to significantly affect the 
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functional application of cognitive abilities which in turn leads to adverse daytime effects 
(Beebe & Gozal, 2002; Jackson, Howard, & Barnes, 2011).  
Beebe and Gozal’s theoretical model bridges the gap between the physiological 
and psychological aspects of OSAS by depicting the effect the intermittent hypoxia and 
hypercarbia have on daytime function (Figure 1). The authors propose a relationship 
between limited tissue oxygen delivery (hypoxia), decreases in intra – and extra – cellular 
pH (hypoxia and hypercarbia), and sleep restoration. Beebe and Gozal further assert that 
blood gas abnormalities and sleep disruption can lead to changes within the central 
nervous system (CNS) that can in turn affect executive dysfunction (Beebe & Gozal, 
2002). The prefrontal model proposed by Beebe and Gozal is not the first model to depict 
an association between the prefrontal cortex and disordered sleep (Harrison & Horne, 
2000). However, no previous studies were identified using the prefrontal model proposed 
by Beebe and Gozal (2002) within the context of OSAS.   
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Figure 1 – Beebe and Gozal’s Prefrontal Model depicting effects of OSAS.  
 
 
 
Modified Theoretical Model   
A synthesized theoretical model will serve as the underpinning for the proposed 
study. The model used for this study was modified from Beebe and Gozal’s (2002) 
prefrontal model of OSAS related sleep disruption to further enhance the applicability of 
the model. As Figure 2 illustrates the modified model is divided into psychological and 
physiological components. The left side of the model illustrates the psychological effect 
of mild OSAS on daytime function. OSAS leads to arousals during sleep that in turn 
result in sleep disruption.  
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Sleep disruption leads to adverse daytime effects such as EDS. This study 
proposed that CPAP use will decrease the associated EDS by minimizing sleep disruption 
from occurring. The recommended amount of nightly CPAP use is defined as machine 
placement of four or more hours a night 70 percent of the nights (Weaver & Grunstein, 
2008), and although widely accepted in clinical practice, this definition is not based upon 
evidence of physiological of psychological response to a particular dose of CPAP. The 
recursive arrows included in the model delineate CPAP use of four or more hours 70 
percent of the nights from CPAP use of less than four hours a night 70 percent of the 
nights. As the arrows infer when CPAP is used four or more hours a night a decrease in 
daytime sleepiness will occur. The feedback loop indicates that when CPAP is used less 
than four hours a night there is minimal improvement in the mild OSAS with possible 
disease progression.  
The current study modified Beebe and Gozal’s model to replace the blood gas 
abnormality hypercarbia with increased sympathetic activity, increased oxidative stress, 
and intermittent hypoxemia. It is clearly demonstrated in the literature that untreated 
OSAS leads to physiological changes in the cardiovascular system that can result in 
hypertension (Buchner et al., 2007; Jaimchariyatam et al., 2010; Laaban et al., 2010; 
Peppard et al., 2000). The primary mechanism behind the association between 
hypertension and OSAS is the increase in sympathetic activity during the periods of 
apnea. Elevated sympathetic activity results in an increase in peripheral arterial resistance 
leading to an increase in diastolic pressure. CPAP use decreases sympathetic activity 
resulting in a decrease in blood pressure. As the arrows suggest in figure 2 when CPAP is 
used four or more hours a night 70 percent of the nights, there is a reduction in 
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sympathetic activity resulting in a decrease in blood pressure. When CPAP is used less 
than four hours a night 70 percent of the nights there is minimal reduction in sympathetic 
activity.  
The number of hours of CPAP use per night to achieve clinical benefits has been 
the focus of several studies. The evidence suggests that better clinical outcomes will be 
achieved with greater use (Engleman et al., 1999; Faccenda at al., 2001; Stradling & 
Davies, 2000; Zimmerman et al., 2006).  It should be noted that clinical benefits have 
been observed with less use than the present CPAP guidelines suggest (Barnes et al., 
2004; Weaver et al., 2007). Campos – Rodriquez et al. (2005) found that CPAP use of 
one hour per night lowered five year mortality rates when compared to no CPAP use. The 
cut point of at least four hours of nightly use 70 percent of nights (although arbitrarily 
assigned) has been used in numerous research studies and will serve as the guidelines for 
recommended use for this study (Aloia et al., 2005; Bachour & Maasilta, 2004; Chasens 
et al., 2005; Lindberg et al., 2006).  
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Summary  
 The literature was reviewed and gaps were identified. Clinical research has 
focused much of its attention on moderate to severe forms of OSAS. Several studies were 
identified examining the effectiveness of CPAP in persons with mild OSAS and the 
impact it has on excessive daytime sleepiness and hypertension, although, additional 
studies are needed. OSAS is a progressive disease and early intervention is imperative. 
OSAS can lead to negative health outcomes at all levels of disease severity.  
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CHAPTER THREE 
METHODS 
Introduction 
 The previous chapter’s literature review examined the concepts of sleep, sleep 
apnea, CPAP therapy, and adherence to CPAP therapy. Many studies have been 
conducted examining the relationship between adherence to CPAP therapy and moderate 
to severe sleep apnea. This study addressed the gap that exists in the literature related to 
the effects of CPAP therapy use in mild OSAS. The following chapter describes this 
study’s design and methods.  
Research Design 
 In order to establish additional evidence of the relationship between CPAP use 
and the outcomes of EDS and blood pressure, a retrospective chart review was 
conducted. A retrospective chart review enabled the researcher to use existing data to 
examine past events and factors to answer the research questions. The following 
hypotheses were addressed:  
H1: Individuals who use continuous positive airway pressure four or more hours a 
night for at least 70 percent of nights recorded will report less daytime sleepiness 
than those who use continuous positive airway pressure less than four hours a 
night at least 70 percent of nights.  
H2: Individuals who use continuous positive airway pressure four or more hours a 
night for at least 70 percent of nights recorded will demonstrate a greater decrease 
in systolic and diastolic blood pressure from baseline than those who use 
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continuous positive airway pressure less than four hours a night at least 70 percent 
of nights. 
Sample Selection and Setting 
 The sample for this study was taken from a physician’s office in a southern state. 
This multi-disciplinary medical clinic specializes in pulmonary diseases and sleep 
disorders with approximately 400 patients seen annually with a diagnosis of obstructive 
sleep apnea. The office manager estimated that of these 400, approximately 120 had a 
diagnosis of mild obstructive sleep apnea.  The goal of this study was to examine the 
relationship of CPAP use on daytime sleepiness and blood pressure. In order to test 
whether CPAP use results in decreases in daytime sleepiness and in systolic and diastolic 
blood pressure from the baseline measure in individuals with mild obstructive sleep 
apnea a priori power analysis was necessary. Conducting a priori power analysis reduces 
the risk that a type II error (accepting a false null hypothesis) will occur (Heavey, 2011). 
The criterion for significance, alpha, was set at 0.05. Alpha is often referred to as a type I 
error. Alpha is the probability that the data analysis will reveal an effect of CPAP use on 
daytime sleepiness and blood pressure that does not actually exist. Power, the probability 
that CPAP use will result in a statistically significant decrease in daytime sleepiness and a 
decrease in systolic and diastolic blood pressure from baseline, was set at 80 percent. 
According to Polit and Beck (2004) 0.8 or 80 percent is the conventional standard for 
power. Using the power program G*Power 3.1.9.2 for the t test family, difference 
between two independent means (two groups) with alpha set at 0.05 and power set at 0.80 
the estimated target sample size was 176, or 88 subjects per group.  
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 The sleep clinic office converted to an electronic medical record (EMR) charting 
system in 2010. Only data within the electronic medical records were collected. Patient 
records were selected for review based on the inclusion criterion: a diagnosis of mild 
obstructive sleep apnea as evidenced by an AHI score between 5 and 14 (i.e., the clinical 
equivalent of mild OSAS), as determined during a full, supervised, standard 
polysomnographic study. Patients were excluded for several reasons including: 1) no 
documented blood pressure or ESS prior to CPAP therapy initiation, 2) no documented 
six week follow up blood pressure or ESS data, 3) no documented data related to CPAP 
use; or 4) diagnosis of cognitive impairment of any type, restless legs syndrome, or 
narcolepsy documented in the EMR. Clinic protocol for patient follow up visits is six 
weeks and annually thereafter.   
Clinic process for reporting CPAP use. After diagnosis of OSAS with overnight 
PSG, the patient is advised to visit the medical supply company of his or her choice to 
obtain the CPAP machine. At that time, the patient is provided with information related 
to proper use of the machine by the medical supply company worker. Each patient is also 
educated regarding how to meet the requirement for a download of CPAP use data. 
According to the sleep clinic office manager where data were collected, patients can 
either, 1) link electronically to the medical supply company and have CPAP use 
automatically downloaded, or 2) visit the medical supply company in person prior to their 
sleep clinic follow up visit and have the data extracted from the machine memory card. 
Regardless of the method of CPAP use data extraction, the medical supply company is 
responsible for sending the CPAP use reports to the sleep clinic office wherein the data 
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are automatically populated into the electronic medical record. The clinic physician then 
has the ability to refer to CPAP machine use at follow-up visits with patients.  
Institutional Review Board (IRB) approval was obtained for this retrospective 
chart review through the University of Wisconsin-Milwaukee (UWM) #13.204 (see IRB 
letter in Appendix A). A letter of support from the clinic physician is located in Appendix 
B.  
 A total of 139 EMR’s were reviewed for this study. Initial review revealed that 79 
participants had incomplete data; meaning one or more of the exclusion criteria were met 
such as no CPAP use documented, incomplete or missing data related to ESS scores or 
blood pressure, or a diagnosis of narcolepsy or restless legs syndrome. The final sample 
size reviewed for this study was 60. Table 1 provides additional data for the excluded 
participants.  
Table 1 
 
Demographics for Excluded Participants 
Mean, standard deviation or percent of sample 
N = 79 
 
 Incomplete data 
N = 13 
No CPAP use reported 
N = 60 
Excluding chronic 
medical condition  
N = 6 
Age  51.8 (SD 13.60) 59.7(SD 12.51) 55.0 (SD 13.93) 
Gender  
  Male  
  Female  
 
9 (69.2) 
4 (30.8) 
 
34 (56.7) 
26 (43.3)  
 
2 (33.3) 
4 (66.7) 
Race  
  Caucasian  
  African American  
 
12 (92.3) 
1 (7.7) 
 
57 (95) 
3 (5)  
 
6 (100)  
Marital status  
  Married  
  Divorced 
  Single/never married 
  Widowed  
 
12 (92.3) 
 
1 (7.7)  
 
50 (83.3) 
8 (13.3) 
2 (3.3)  
 
3 (50) 
2 (33.3) 
 
1 (16.7)  
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Measures  
Age, race, gender, and marital status provided information for describing the 
demographics of the sample. Age was determined from the date of birth. Age is a 
significant variable due to the existing research that suggests that sleep related difficulties 
increase with increased age (Malhorta et al., 2006). Race was recorded as Caucasian, 
African American, or other, since no other races or ethnicities were represented within 
this patient population. A study conducted by Means, Ulmer, and Edinger (2010) found 
that African Americans used their CPAP therapy one less night per week and one less 
hour per night than their Caucasian American counterparts. Gender was recorded as male 
or female. The male predisposition for OSAS has been attributed to sex differences in 
anatomical and functional properties of the upper airway, hormones, and respiratory 
control stability (Lin et al., 2008).  Marital status was recorded as married, divorced, 
single / never married, widowed, or separated. Marital status data were collected in the 
sleep clinic office as a single question, “marital status.” This collection method may have 
led to heteronormative data.  Gagnadox et al. (2011) conducted a large clinical study 
involving patient’s prescribed CPAP therapy and found marital status to be an 
independent factor of CPAP adherence.  
AHI scores were recorded for each participant from the polysomnogram prior to 
CPAP therapy initiation. The sleep clinic office uses both AHI and RDI scores to 
diagnose mild OSAS. AHI and RDI values were reportedly used by this sleep medicine 
practice to categorize OSAS as mild, moderate, or severe  (mild OSAS AHI – 5-14,  
moderate OSAS AHI – 15-30,  severe OSAS AHI - >30, ) (Berry et al., 2012). However, 
for this study, OSAS was categorized by AHI value only, since this is standard practice in 
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OSAS research (Jainchariyatam et al., 2010; Takama & Kurabayashi, 2010). Additional 
information was gathered related to smoking and positive airway pressure use. Current 
smoking status was recorded as “yes” or “no”. Positive airway pressure was recorded as 
continuous positive airway pressure, automatic positive airway pressure, or bilevel 
positive airway pressure. Machine manufacturer, machine pressure setting, and the use of 
supplemental oxygen with the positive airway pressure were also recorded. Machine 
manufacturer responses were RESMED, Respironics, Sandman, Fisher and Paykel, 
Cascade, and other. Machine pressure setting was measured in centimeters of water 
pressure and supplemental oxygen use was recorded as “yes” or “no”. CPAP use was 
documented as the number of days included in the most recent report available to the 
sleep clinic office and the percent of days during the report when CPAP was used greater 
than or equal to four hours a night and the percent of days when CPAP was used less than 
four hours a night.  
Information related to current medications was gathered from the EMR. Of 
specific interest to this study were antihypertensive medications. Antihypertensive 
medication classifications included angiotensin converting enzyme inhibitors, angiotensin 
II receptor antagonists, beta blockers, diuretics, and calcium channel blockers. A wide 
range of other medications was gathered from the EMR that were not thought to affect 
blood pressure or daytime sleepiness. These included, but were not limited to, 
medications used to treat diabetes, gastrointestinal disorders, hyperlipidemia, and 
vitamins.  
Diagnoses related to chronic medical conditions were recorded as follows; 
hypertension, restless legs syndrome, narcolepsy, diabetes mellitus, depression, 
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cardiovascular disease, obstructive sleep apnea syndrome, and other.  Data were collected 
on chronic medical conditions for descriptive purposes as well as participant exclusion 
(i.e., narcolepsy, restless legs syndrome).  
Epworth Sleepiness Scale (ESS) scores, blood pressure, oxygen saturation, neck 
circumference, and weight information were collected from the EMR from the initial visit 
(prior to CPAP therapy), and at follow up visits that occurred at or around six weeks, one 
year, two years, and 3 years.   
Daytime sleepiness was measured by the patient’s ESS scores, which was 
completed at each patient visit. Blood pressure measurements were also recorded at each 
patient visit. The amount of CPAP use for each patient was made available to the sleep 
clinic via fax from the medical supply company that supports the particular sleep apnea 
machine used by the patient as previously described. Some patients had the option to 
have their CPAP use automatically downloaded and sent to the medical supply company 
without having to physically go to the medical supply company. The EMR did not record 
whether patients physically delivered their memory storage device to the company or 
used the automatic download option. CPAP use was summarized in each EMR and 
included the number of days included in the report (which varied depending on the last 
time the report was downloaded from the CPAP machine) and the percent of days that the 
patient used the device for 4 or more hours a night.  
Epworth Sleepiness Scale. The following evidence demonstrates that the 
Epworth Sleepiness Scale (ESS) is a widely used questionnaire designed to measure 
subjective sleepiness (Johns, 1991). The ESS questionnaire consists of eight items that 
address typical day- to- day situations and is intended to differentiate individuals with 
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excessive daytime sleepiness from alert individuals (see Appendix C). Each item is 
scored from 0 to 3 points (0 = would never doze, 3 = high chance of dozing). Responses 
to individual questions are summed for a possible range of 0 to 24. A score of 10 or 
greater is indicative of excessive daytime sleepiness (Gander et al., 2005).  
 Evidence for the validity of the ESS was reported by Johns (1991) who conducted 
a study of 180 adults, including 150 patients with a range of known sleep disorders and 
30 normal women and men as controls. This study was conducted to assist in determining 
whether the ESS was a valid tool for assessing daytime sleepiness. Lower ESS scores 
were reported for controls than for OSAS, narcolepsy, and idiopathic hypersomnia (p < 
0.001). In addition, concurrent validity of the ESS was established in this study. ESS 
scores were significantly correlated to sleep latency (the amount of time it takes an 
individual to fall asleep after the lights are turned off) as measured by overnight 
polysomnography (p < 0.001). Furthermore, in subjects with OSAS, ESS scores were 
significantly correlated with the apnea - hypopnea index (p <0.001) (Johns, 1991).  
The reliability of the ESS was investigated in a second study conducted by Johns 
(1992). Eighty-seven healthy subjects were asked to complete the ESS at baseline and 
again 5 months later. Test – retest reliability was demonstrated by a high correlation (r = 
0.82) between the paired tests. Item analysis of two different groups of subjects (healthy 
subjects and individuals with a variety of sleep disorders) demonstrated a reliability of α 
= 0.88 and 0.73, respectively. Factor analysis of the items on the ESS demonstrated that 
the questionnaire measures only one factor (Johns, 1992).  
 Spira et al. (2012) conducted a study to examine the reliability and validity of the 
ESS. In the study involving 3,059 men the ESS demonstrated moderately adequate 
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internal consistency as measured by Cronbach’s alpha of α = .70 and an item-total 
correlations range from .30 to .51. Beaudreau et al. (2012) also examined the validity of 
the ESS in a study involving 2,968 women. The ESS demonstrated adequate reliability in 
the total sample (α = .76). Correlations between the ESS and theoretically relevant 
measures were weak but were statistically significant (daytime inactivity, p = <0.001, r = 
0.15; total sleep time, p= <0.001, r = -0.19; wake after sleep onset, p= 0.01, r = 0.05). 
 Blood pressure. The standard of practice at the sleep clinic is to assess blood 
pressure at each visit using a manual sphygmomanometer. Both systolic and diastolic 
pressures readings were extracted from the electronic medical record. 
 
Procedure for Data Collection 
 IRB approval was obtained and the PI met with and trained the office manager on 
the use of the data collection tool (Appendix D). The office manager worked on her own 
time to collect the data and was compensated. Data were collected on mild OSAS 
patients from electronic medical records (EMR) only. After the data collector collected 
data from 25 EMR’s the PI reviewed the data that had been collected for quality control 
purposes. The data collector coded the data collection sheets prior to PI review to ensure 
anonymity.  Blood pressure and ESS scores were extracted from the EMR for each 
participant prior to the initiation of CPAP therapy and at six weeks follow up, 1 year 
follow up, 2 year follow up, and 3 year follow up. The time period for the follow up visits 
is based on clinic protocol. The 3 year follow up is the last visit for data collection due to 
the length of time the clinic has been using the EMR system.  
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Independent variable  
 The independent variables for this study were the two groups of CPAP use; those 
who used CPAP four or more hours a night and those who used CPAP less than four 
hours a night.  CPAP use is defined by the number of hours a person uses the device 
during a 24 hour period. The recommended amount of use is four or more hours of 
nightly use 70 percent of the nights (Weaver & Grunstein, 2008). Data were recorded in 
the EMR as the percent of days with CPAP use of four or more hours and the percent of 
days with CPAP use less than four hours as reported by the manufacturer of each CPAP 
machine and entered into the EMR.  
Dependent Variables 
 The dependent variables in this study were daytime sleepiness and blood pressure. 
Daytime sleepiness was measured using the ESS.  Blood pressure and ESS scores were 
documented in the EMR at each clinic visit. Blood pressure was represented by two 
values, diastolic and systolic. This study examined both values separately to determine if 
one or both values were affected by CPAP use. The standard of practice at the clinic is 
that after a diagnosis has been made of OSAS the patient will follow up at six weeks, and 
then annually thereafter. The time periods for data collection for this study were baseline 
(prior to CPAP therapy initiation), 6 weeks, 1 year, 2 years, and 3 years. The collection 
time points are based on clinic protocol.   
Human Subjects Protection Procedures 
          Data were extracted from the EMR by the data collector. At the time of data 
extraction each data collection sheet was assigned a study identification number. The data 
collector will keep a list that links the study identification number with the medical 
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record in her office for a period of two years after the study at which point the list will be 
shredded. After IRB approval was obtained the PI received de-identified data. The PI 
made no attempt to identify study participants. All information obtained for this study is 
stored on a secure, password protected computer.  
Data Analysis 
Data were analyzed using the Statistical Package for the Social Sciences (SPSS) 
Version 21.0. Descriptive statistics were used to analyze the demographic data obtained. 
Frequencies were computed for age, race, gender, and marital status. Descriptive 
statistics provided a description of the research participants.   
The aim of this study was to examine the effect CPAP use had on daytime 
sleepiness and blood pressure. The final sample was divided into two groups, those who 
used CPAP four hours or more a night for 70 percent of nights (Group A) and those who 
used less than this amount (Group B). Both research questions were answered by 
comparing group means using independent t-tests. A t-test at baseline demonstrated no 
differences between the groups. As a result, the difference in scores between baseline and 
follow-up were calculated for each study variable (ESS scores, systolic blood pressure, 
diastolic blood pressure) and three independent t-tests were run (see Table 8).  
Summary 
 This retrospective chart review provided quantitative data to address the research 
questions “How does continuous positive airway pressure affect daytime sleepiness?” and 
“How does continuous positive airway pressure therapy affect blood pressure?” This 
methodology section provided the following information: a description of the research 
design, sample selection and setting, instrumentation, procedure for data collection, a 
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description of the independent and dependent variables, as well as the statistical 
procedures that were utilized.  
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CHAPTER FOUR 
RESULTS 
 This chapter presents study analysis results. First there will be discussion of the 
study participants’ sample size and demographics. Then the final data analysis will be 
presented.  
Demographics  
 The final sample included only participants who had documented CPAP use (n = 
60). These participants were further divided into two groups:  
 Group A: Those with documented use of CPAP four or more hours a night 70% of the 
recorded nights (n = 45), and  
 Group B: Those with documented use of CPAP for less than four hours a night 70 
percent of the recorded nights (n = 15).  
Each of the 60 participants had pre-CPAP and six week follow up visits for ESS scores, 
blood pressure, or both (see Table 2). This study experienced significant loss of 
participants due to lack of complete EMR data (see Figure 3). The data available at the 
one, two, and three year follow ups were limited and therefore were not included in the 
final analysis.  
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Table 2 
 
  
Patients with Documented  Blood Pressure, ESS, or Both   
 Pre CPAP and 6 
week follow up   
Pre CPAP, 6 
week, and 1 
year follow 
ups 
Pre CPAP, 6 
week, 1 and 2 
year follow ups 
Pre CPAP, 6 
week, 1, 2 and 3 
year follow ups  
Variable   N %   n %     n      % n        
Blood pressure only  54 90   26 43     8      15 0 
ESS score only  36 60   10 17     1       2 0 
Blood pressure and 
ESS score  
 30 50    6 10     1       2  0 
 
Figure 3 
 
Number of Participants with Documented Blood Pressure, ESS Scores, or Both 
  
 
The final sample (n = 60) was 56.7 percent male, 43.3 percent female, and 98.3 
percent Caucasian (see Table 3). Forty four participants (73%) were currently taking a 
medication(s) that could be used to treat hypertension and 96.7 percent had at least one 
chronic medical condition other than OSAS. The three most frequent conditions reported 
were obesity (55%), hypertension (58.3%), and diabetes mellitus (15%). The mean AHI 
0
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score was 9.7(2.89) and RDI was 10.0(3.12). CPAP was the only type of positive airway 
pressure reported as being used and 95 percent reported not using supplemental oxygen 
with the CPAP. Clinic protocol for OSAS treatment is six week follow up followed by 
annual follow up visits. It is not uncommon for a patient to seek medical treatment for 
OSAS complications outside of the clinic protocol. For the sample above, 9 (15%) sought 
treatment outside of the clinic protocol once and 2 (3.3%) sought treatment outside of the 
clinic protocol twice. No further exploration of frequency of follow up visits outside of 
clinic protocol was conducted due to limited data.  
The demographic characteristics of Groups A and B were similar (see Table 3). 
The mean ages of participants in Group A was 62 and Group B was 59. Both groups were 
approximately one half male, predominately Caucasian, married, and non-smokers. A t-
test was conducted to compare age between the groups and found no statistical difference 
t (58) = .770, p = .445 between Group A (μ = 62, SD 11.82) and Group B (μ = 59.1, SD = 
14.40).  There were 2 (4.4 percent) in Group A and 1 (6.7 percent) in Group B who used 
supplemental oxygen with their CPAP. The mean age for the two in Group A who 
received supplemental oxygen with their CPAP was 64 (9.90); they were white, non-
smokers, one widowed female and one married male. The one participant in Group B 
receiving supplemental oxygen was a 62 year old white, non-smoking, married female. 
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Table 3 
 
Demographics, Supplemental Oxygen Use, and CPAP use for Both Groups  
 Group A  
n= 45 
Group B 
n = 15 
Age 62 (11.82) 59.1 (14.40) 
Gender    
Male  27 (60) 7 (46.7) 
Female 18 (40) 8 (53.3) 
Race    
Caucasian American 45 (100) 14 (93.3) 
African American   1 (6.7) 
Marital Status    
Married 36 (80) 12 (80) 
Divorced  2 (4.4) 3 (20) 
Single/never married 2 (4.4)  
Widowed  3 (6.7)  
Separated  1 (2.2)  
Smoker    
No  39 (86.7) 14 (93.3) 
Yes  6 (13.3)  1 (6.7) 
Supplemental oxygen therapy with 
CPAP  
  
No 43 (95.6) 14 (93.3) 
Yes  2 (4.4) 1 (6.7) 
 
CPAP Use  
The number of days included in the CPAP use report is highly variable with a 
range of 354 days for those who used CPAP four or more hours a night and a range of 
104 days for those who used CPAP less than four hours a night (see Table 4). Data 
collected related to CPAP use included the number of days in the most recent report 
submitted to the sleep clinic, percent of days with usage of four or more hours a night, 
and percent of days with usage of less than four hours a night. The average number of 
days included in the CPAP use report for Group A was 69.4 (66.90) days and the average 
number of days included for Group B was 53 (34.74).  The median for number of days 
included in the CPAP report was 37 (Group A) and 42 (Group B).  
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Table 4 
 
Days of CPAP Use Reported  
  
 μ, SD, M  
Group A,  n= 45 69.4 (66.90), 37  
Group B,  n = 15 53 (34.74), 42  
Note. Range of days included in CPAP use report for Group A was 11-365. Range of days included in 
CPAP use report for Group B was 13-117.  
  
Findings for Analysis  
Table 5 illustrates the mean changes in ESS scores for the two groups. The ESS 
score range for Group A was 0-20 and the range for Group B was 0-16. The mean ESS 
score prior to starting CPAP (i.e., baseline) did not vary significantly between Group A 
(10.2) and Group B (10.0); however both groups met the criteria for having clinically 
significant levels of daytime sleepiness. Prior to being prescribed CPAP therapy, 55 
percent (n = 15) of Group A reported ESS scores greater than or equal to 10, while 63 
percent (n = 5) of Group B reported ESS scores greater than or equal to 10. At the six 
week follow-up, both groups reported a dramatic decrease in sleepiness to clinically 
insignificant levels (see Table 5) with 11 percent (n = 3) of Group A reporting ESS scores 
greater than or equal to 10 (clinically excessive daytime sleepiness) and none of those in 
Group B reporting ESS scores greater than or equal to 10.  
Table 5 
 
ESS Scores at Six Week Follow Up, n = 36 
 Group A, n=28                                                  
μ (SD)                                                 
Group B, n = 8 
μ (SD)                                                 
preCPAP  10.2 (4.58) 10.0 (4.63) 
6 week follow up  3.6 (4.17) 1.9 (1.73)  
Note: ESS reference norms – 0-9 = average amount of daytime sleepiness, 10 or > = excessive daytime 
sleepiness. Maximum possible score is 24 (Johns, 1991). 
 
Table 6 illustrates the effects on blood pressure based on the American Heart 
Association (AHA) guidelines on hypertension in blood pressure from baseline to six 
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week follow up. In order to examine the groups more closely for blood pressure changes, 
baseline and six week follow up blood pressure readings were reviewed based on the 
AHA hypertension guidelines. There were a total of 54 participants who had blood 
pressure data available at baseline and the six week follow up visit. Of the 54, eight were 
normotensive at baseline, four demonstrated no change in blood pressure at six week 
follow up (Group A, n = 3; Group B,  n = 1) and four demonstrated an increase in blood 
pressure (prehypertension, stage 1, or stage 2 hypertension) (Group A , n = 4). There 
were 24 participants who were prehypertensive at baseline. Of the 24 with 
prehypertension, 13 demonstrated no change in blood pressure at the six week follow up 
(Group A, n = 11; Group B , n = 2), three demonstrated a decrease (normotensive) (all 
Group A), and eight demonstrated an increase (stage 1 hypertension) (Group A , n =5, 
Group B, n = 3).  Of the 54 participants with blood pressure data at the six week follow 
up, 16 had stage 1 hypertension  (Group A, n = 13, Group B, n =3 ) and six had stage 2 
hypertension (Group A , n = 2 , Group B, n = 4) at baseline. A total of five with stage 1 
hypertension demonstrated no change (Group A, n = 4, Group B, n = 1) and 11 
demonstrated a decrease (Group A, n = 9, Group B, n = 2).  Of those with stage 2 
hypertension, one demonstrated no change (Group B) and five demonstrated a decrease 
(Group A, n = 1, Group B, n = 4). Eighty five percent of those who had blood pressure 
data at baseline and six week follow up were either prehypertensive (44 percent) or 
hypertensive (41 percent) (stage 1 – 11 percent, stage 2 - 30 percent). 
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Table 6 
 
Effects on Blood Pressure, n = 54 
 Group A, n = 41 Group B, n =13 
No change  n = 18 (44) n = 5 (38.5) 
Decrease  n = 14 (34) n = 5 (38.5) 
Increase n = 9 (22) n = 3 (23)  
 
Table 7 and Figure 4 illustrate the mean decrease in blood pressure for both 
groups. There was a decrease in systolic blood pressure of 1.1 mmHg for Group A 
compared to a decrease of 5.8 mmHg for Group B. Decreases in diastolic blood pressure 
were similar; Group A demonstrated a decrease of 0.4 mmHg while Group B 
demonstrated a decrease of 4 mmHg. A greater decrease in mean systolic and diastolic 
blood pressures was noted for Group B than for Group A.  
Table 7  
 
Blood Pressure Measurements (mmHg) at Six Week Follow Up  
 Group A,  n = 41                                             
μ (SD)                                                 
Group B, n = 13 
μ (SD)                                                 
Pre CPAP systolic  
6 week systolic  
130.6 (15.02) 
129.5 (13.42) 
139.5 (15.71) 
133.7 912.02) 
Pre CPAP diastolic  
6 week diastolic  
79.3 (9.26) 
78.9 (8.91)  
84.8 (13.03) 
80.8 (9.00)  
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Figure 4  
 
Blood Pressure Measurements (mmHg) at Six Weeks Follow Up  
 
T – tests were run at baseline for daytime sleepiness (t [43] = .411, p = .683), 
systolic blood pressure (t [57] = 1.200, p = .235), and diastolic blood pressure (t [53] = 
1.133, p = .176) to determine if significant differences existed between the groups at 
baseline. It was determined that there were no differences between Groups A and B at 
baseline. Therefore, difference scores were calculated on each variable for each group 
from baseline to 6 weeks follow up. Three independent samples t – tests were conducted 
on the difference scores to examine the effect CPAP use had on daytime sleepiness, 
systolic blood pressure, and diastolic blood pressure (Table 8).  
Table 8 
 
Independent Samples t Test Results on Difference Scores for Daytime Sleepiness, Systolic Blood Pressure, 
and Diastolic Blood Pressure  
 Μ t (df) p CI (95%)  
ESS  1.5 .865 (34) .393 -2.049 – 5.084  
Systolic blood pressure 4.7 .911 (52) .367 -5.653 – 15.053   
Diastolic blood pressure  3.6 1.00 (52) .321 -3.617 – 10.837  
Note. Mean reported is the mean difference score for each variable.  
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Summary  
 Overall, the findings did not reveal significant differences between those who 
used CPAP four or more hours a night 70 percent of reported nights (Group A) and those 
who used CPAP less than four hours a night 70 percent of reported nights (Group B) 
from baseline to six-weeks follow-up. However, both groups demonstrated clear 
reductions in daytime sleepiness from baseline to six week follow-up. Paradoxically, 
Group B demonstrated greater decreases at the 6 week follow-up on all three variables 
than Group A. These findings will be placed in the context of the literature in chapter 
five.  
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CHAPTER FIVE 
DISCUSSION 
 The purpose of this study was to examine the relationship of CPAP use to the 
outcomes of daytime sleepiness and blood pressure in persons with mild obstructive sleep 
apnea. Although this study found no significant differences between CPAP use and 
daytime sleepiness or blood pressure, these results can still inform future directions for 
research, policy, and practice. This chapter will address findings and limitations of this 
retrospective chart review on daytime sleepiness, blood pressure and blood pressure 
medication use, and CPAP use reporting within the context of the existing literature. As a 
reminder, obstructive sleep apnea is categorized as mild (AHI 5-14), moderate (AHI 15-
30), or severe (AHI >30).  
Continuous Positive Airway Pressure (CPAP) Use and Daytime Sleepiness  
 In this retrospective chart review, the data available at the one, two, and three year 
follow up were so limited that this time point was not included in the final data analysis. 
Hypothesis 1: Individuals who use continuous positive airway pressure four or more 
hours a night will report less daytime sleepiness than those who use continuous positive 
airway pressure less than four hours a night. Although daytime sleepiness scores 
decreased substantially for both groups, the reduction did not reach the level of statistical 
significance when the groups were compared. The decrease was, however, clinically 
significant for both groups. Noting that an ESS score >10 is considered clinically 
significant sleepiness, the percent of participants in each group with clinically significant 
sleepiness dropped dramatically from baseline to six weeks (Group A dropped from 55% 
to 11%; Group B dropped from 63% to 0%).  That both groups changed from having 
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clinically significant sleepiness before CPAP initiation to having nearly no daytime 
sleepiness is a clinically significant finding.  Paradoxically, those in Group B reported a 
greater decrease in daytime sleepiness than those in Group A.  Due to the small sample 
size, the findings may be indicative of random variability, especially given the lack of 
statistical significance between the groups.    
 Marshall et al. (2006) found ESS scores to be significantly reduced (1.2 points) 
with the use of CPAP in the mild to moderate OSAS population. However, ESS scores 
were not significantly decreased in the mild OSAS population in several other studies 
previously reviewed (Barnes et al., 2002; Engleman et al., 1997; Monasterio et al., 2001). 
A large amount of the current literature related to treatment of mild OSAS involves the 
use of oral appliances (Doff et al., 2013; Leite et al., 2013) and surgical treatment with 
uvulopalatoplasty (Balsevicius, Uloza, Vaitkus, Sakalauskas, & Miliauskas, 2013). CPAP 
use is currently optionally indicated for the treatment of patients with mild OSAS. 
Kushida et al. (2006) recommends that additional research is needed to validate its use in 
this population, and the findings from the current study also support this 
recommendation.  
Continuous Positive Airway Pressure (CPAP) Use and Blood Pressure  
 Similar to daytime sleepiness scores, data collected at the one, two, and three year 
follow up visits were so limited that they were not included in the final data analysis. H2: 
Individuals who use continuous positive airway pressure four or more hours a night will 
demonstrate a greater decrease in systolic and diastolic blood pressure from baseline 
than those who use continuous positive airway pressure less than four hours a night. The 
results of this study did not find statistically significant differences in blood pressure 
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between the groups for either systolic or diastolic blood pressure at six weeks. There was 
a mean decrease in systolic blood pressure of 1.1 mmHg for Group A and a mean 
decrease of 5.8 mmHg for Group B. Results were similar for diastolic pressure where 
Group A decreased on average 0.4 mmHg and Group B decreased 4 mmHg. Similar to 
sleepiness scores, Group B demonstrated greater decreases in both systolic and diastolic 
pressure at six week follow up than Group A, which was an unexpected finding.  
Based on the AHA hypertension guideline definitions of hypertension, 44 percent 
of Group A demonstrated no change in blood pressure, 34 percent demonstrated a 
decrease in blood pressure, and 22 percent demonstrated an increase in blood pressure. In 
Group B, 38 percent demonstrated no change in blood pressure, 38 percent demonstrated 
a decrease in blood pressure, and 23 percent demonstrated an increase in blood pressure. 
Although not statistically significant, perhaps due to the small sample, overall those in 
Group B demonstrated greater reductions in both systolic and diastolic blood pressure 
than those in Group A.  
It is noteworthy to mention that 83 percent of those with either prehypertension or 
hypertension at baseline demonstrated no change or a decrease in blood pressure, and 17 
percent demonstrated an increase in blood pressure at the six week follow up. This 
finding suggests that CPAP use, at varying doses, may effectively reduce or prevent 
further progression of hypertension in some OSAS patients, but further investigation of 
this relationship is necessary. 
Changes in blood pressure (systolic and diastolic) have been observed in as little 
as one month in a population with an AHI of 10 or greater (Pepperell et al., 2002), two 
months with an AHI of 10 or greater (Logan et al., 2003), and three months in a 
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population with a mean AHI of 30 or greater (Hui et al., 2006). Pepperell et al. (2002) 
found significant decreases (p = 0.0013) in mean arterial blood pressure with therapeutic 
CPAP use at one month. Based on the above studies, the current study should have 
revealed a decrease, or at the minimum, a trend toward lower blood pressure. It should be 
noted that Pepperell et al. (2002) found a greater benefit for those taking blood pressure 
medications than for those not taking blood medications. The current study was unable to 
control for blood pressure medications due to insufficient data available in the EMR (i.e., 
medication name, dose, frequency) to accurately control the variable. Furthermore, it was 
not known if the prescribed medication was primarily being used to treat hypertension or 
another medical condition.  
Pepperell et al. (2002) found a greater decrease with those who had a more severe 
form of the disease. Jaimchariyatam et al. (2010) conducted a retrospective study of mild 
OSAS subjects comparing those who used CPAP (n = 93) to those who did not use CPAP 
(n = 162) over a two year period. Those who used CPAP experienced a 1.97 point 
decrease in mean blood pressure compared to a 9.61 point increase in those who did not 
use CPAP.  Based on the results of Jaimchariyatam et al. (2010) it is plausible that 
persons with mild OSAS could experience a decrease in blood pressure with long term 
use. Additional studies are needed to confirm this supposition. The small sample size for 
the current study may explain the lack of statistical significance. Complexities in defining 
groups by the definition of four or more hours per night for 70 percent of recorded nights 
may also have washed out an existing effect, which will be further discussed later.  
Several studies have shown that CPAP use can reduce the blood pressure of 
OSAS patients (Akashiba et al., 1999; Faccenda et al., 2001; Pepperell et al., 2002). 
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However, these studies included primarily patients with moderate to severe OSAS. The 
study with the largest patient population was conducted by Borgel et al. (2004) on 196 
moderate to severe OSAS patients. The authors found a statistically significant decrease 
in diastolic blood pressure among those participants using CPAP for six months (p = 
.001).  Borgel et al. (2004) also found independent relationships between the severity of 
the OSAS and diastolic blood pressure (p = .003) and systolic blood pressure (p = .014). 
The relationship between disease severity and CPAP use contributes to the ambivalence 
related to treating persons with mild OSAS with CPAP therapy.  Baguet et al. (2009) 
assert that CPAP is more effective on blood pressure if the OSAS is severe.  
Results from another study conducted with persons with mild OSAS are conflicting. 
Barnes et al. (2002) conducted a study involving 28 patients with mild OSAS where mild 
OSAS was defined as an AHI of 5 - 30. The participants had 24 hour blood pressure 
measurements obtained at baseline, after eight weeks of CPAP treatment, and after eight 
weeks of treatment with an oral placebo tablet.  CPAP use did not result in statistically 
significant findings related to 24 hour blood pressure readings. The authors did not 
postulate as to why the CPAP users did not have a decrease in blood pressure.  The 
results of the Barnes et al. (2002) study are similar to those found in the current study. 
Given the progressive nature of OSAS, additional studies examining the effectiveness of 
treating the disease during the early stages are warranted. The results of this study were 
based on intermittent clinic-acquired readings. A better measurement plan for 
understanding the effects of CPAP use on psychological and physiological outcomes 
would involve more frequent readings.  
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Findings Summary 
 The purpose of this study was to examine the relationship of CPAP use on the 
outcomes of daytime sleepiness and blood pressure in persons with mild OSAS, however 
no statistically significant differences were noted at the six week follow up for daytime 
sleepiness or blood pressure. The small sample size might explain the lack of 
significance. Another possible explanation for lack of significance in blood pressure was 
not controlling for blood pressure medications.  
 A common clinical dilemma in the literature appears to be at what level of disease 
severity a person with OSAS should be treated with CPAP (Barnes et al., 2002; 
Engleman et al., 1997; Marshall et al., 2005). The literature examining the use of CPAP 
in persons with mild OSAS continues to evolve. Although the use of CPAP in the sample 
for this study did not result in statistically significant findings in regards to daytime 
sleepiness or blood pressure, clinical significance could be considered in regards to 
daytime sleepiness. The mean reduction in ESS scores for participants in this study was 
6.6 points for those who used CPAP four or more hours a night 70 percent of nights, 
compared to a mean reduction of 8.1 points for those who used CPAP less than this 
amount. Considering that an ESS score of 10 or greater is indicative of excessive daytime 
sleepiness this reduction, which was seen in both groups, may be clinically significant 
even though the level of statistical significance was not reached between groups. The 
mean reduction in blood pressure for those participants who used CPAP four or more 
hours a night 70 percent of nights was 1.1 mmHg decrease in systolic and a 0.4 mmHg 
decrease in diastolic, compared to a mean reduction of 5.8 mmHg decrease in systolic 
and a 4 mmHg decrease in diastolic for those who used CPAP less than four hours a night 
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70 percent of nights. Neither group had a decrease in blood pressure (systolic or diastolic) 
that reached the level of significance.  A decrease of 5.8 mmHg systolic and 4 mmHg 
diastolic for those who used less than four hours a night 70 percent of nights may be 
clinically significant, however, this finding is limited by the small (n = 13) sample size. 
Limitations  
Limitations to this study involved data collection, CPAP usage reporting, CPAP 
use definition, and generalizability of the results. The retrospective chart review 
conducted for this study presents several limitations, including but not limited to 
incomplete or missing data within the medical record, difficulty verifying documented 
information, and variability in the quality of documentation by health care personnel. 
Data available in the patient medical record are primarily collected for the purpose of 
providing clinical care and are often not comprehensive.  
The sleep clinic office where data were collected converted to an EMR system 
approximately three years before these data were collected. All patients seen in the sleep 
clinic office in the last three years were included in the study. However, it became 
apparent that some of the participants had data from earlier than three years and had 
begun CPAP therapy prior to the initiation of the EMR system. Therefore, original data 
had to be manually transferred from the paper record to the EMR. The process of manual 
entry may have resulted in data being missed, skipped, or incorrectly entered. Several 
variables collected for this study are subject to change over time (marital status, chronic 
medical conditions, and current medications) and it is plausible that these changes were 
not reflected in the EMR. A total of 73 participants were excluded from this study due to 
incomplete or missing data (13 incomplete data, 60 missing CPAP use data). The author 
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does not presume those with incomplete or missing data to be any different from those 
who had complete data documented. Review of the data collection sheets led the author 
to reach the conclusion that the incomplete and missing data is either the result of the data 
entry process during the transition from paper to electronic records or lack of 
documentation.   
For healthcare researchers, there are obstacles to digitalization of medical records. 
The data collected for the EMR are not done so for research purposes, therefore lack of 
standardization related to medical conditions, laboratory tests, disease staging, etc., can 
hinder the data collection phase of the research process. Additionally, inconsistent data 
entry across sites also presents challenges for health care researchers (Dean et al., 2009).  
Overall, current methods of utilizing EMR systems are not sufficient. The quality of care 
provided, as well as the utilization of data for research, may be compromised due to 
incomplete or missing data.  
One of the aims of this study was to examine the effect of CPAP use on blood 
pressure. Due to insufficient data related to medication use it was not possible to control 
for blood pressure medication use in this study. Data were gathered regarding medication 
use specific to those medications that could be used to treat hypertension. However, 
medications used to treat hypertension can also be used to treat various other medical 
conditions (i.e., congestive heart failure, vascular headaches, and cardiac dysrhythmias). 
It was unknown from the data collected whether the participant was taking a specific 
blood pressure medication to treat hypertension or for another health condition. 
Identifying those who take multiple medications for the treatment of hypertension would 
have provided data related to individuals with resistant hypertension (requiring at least 
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three antihypertensive medications). It is estimated that greater than 70 percent of 
individuals with resistant hypertension also have a diagnosis of OSAS (Logan et al., 
2001). Those data could have provided additional information regarding the resistant 
hypertension population. It was also unknown how each participant took their blood 
pressure medication (e.g., dosage, frequency). It is also plausible that changes in 
medication use could have occurred and not been documented in the EMR.  
The sleep clinic procedure for documenting CPAP use was also a limitation of 
this study. The actual number of hours a patient used CPAP was not available. The data 
available in the EMR was the number of days included in the report and the percent of 
the days when the CPAP was used four or more hours a night and the percent of the days 
when the CPAP was used less than four hours night. In light of the findings of this study, 
and given a possible dose-response relationship between CPAP use (Stepnowsky & 
Dimsdale, 2002; Weaver et al., 2007) and possible health benefits, more specific data 
related to the number of hours a patient used the CPAP would have been beneficial to this 
study.   
The reporting method by manufacturer for CPAP use was another limitation of 
this study. CPAP machine type varied among participants. There were a total of five 
different machines identified as used by participants in this study. There were three 
participants who used a machine other than the five listed on the data collection tool. 
While all machines used in this study have the capability of providing a summary report 
of usage, there is some degree of variability in how the reports are compiled. Compliance 
summaries are provided by request from either patient or physician for whatever time 
period desired. Therefore, reports frequently vary in the number of days summarized.  
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CPAP use reports are generated by the medical supply company that supports the 
particular CPAP machine used by the patient. The patient is responsible for taking the 
data storage device from their machine to the medical supply company prior to the visit 
so the report can be generated and faxed to the sleep clinic. Patients are also able to 
perform automatic downloads from the machine. It was not known from the EMR how 
the patient provided data on CPAP use to the sleep clinic. The method in which the data 
is provided should not have any impact on the results of this study, but the lack of control 
in this variable is a data collection limitation.  
A major point of concern for this study was the lack of data available in the EMR 
related to CPAP use. It may be presumed that those who use the CPAP machine likely 
follow up with their sleep medicine provider and that those who do not use the CPAP 
machine are less likely to follow up with their sleep medicine provider. With that 
presumption, it is plausible that those without CPAP uses documented are in fact using 
their CPAP machine, but do not have evidence to support the use in the EMR. This lack 
of evidence could be due to the patient or the medical supply company failing to make 
the CPAP use data available or it could be that data were lost or not properly entered into 
the EMR during the transition from paper records. Direct data collection from 
participants in future studies would help to minimize these limitations. 
This study provides evidence to support the need for development of a standard 
reporting procedure for companies that manufacture CPAP machines. Requiring machine 
manufacturers to report usage following the same format could result in more accurate 
tracking of patient use. Positive airway pressure machine manufacturers could also be 
required to link CPAP use data to EMR’s providing automatic population of data to entry 
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fields needed for health care providers to adequately evaluate CPAP use. Patients are 
treated at the sleep clinic office with or without a CPAP usage report. If a usage report is 
not available, the physician gathers the patient’s subjective report of use and bases 
treatment on that report.  
Generalizability of this study’s findings is limited due to a lack of power resulting 
from the small sample size. The initial data collection included 139 participants. A 
number of participants were excluded from this study (n = 79) for lack of data 
availability. The lack of data available in the EMR for data collection likely impacts 
generalizability. 
Theory Implications 
 The Beebe and Gozal Prefrontal Model (Figure 1) was modified (Figure 2) and 
served as the theoretical underpinning for this study. When re-visiting the theoretical 
model in light of these findings it seemed that although not statistically significant, the 
initiation of CPAP brought about more changes to daytime sleepiness in persons with 
mild OSAS than changes in blood pressure. Those who used CPAP and those who did 
not use CPAP decreased from clinically excessive daytime sleepiness (ESS >10) to 
virtually no daytime sleepiness at the six week follow up.   
 In light of these findings, the model was revised (Figure 5). The revised model 
removes the specified number of hours per night of CPAP use. The revision will allow 
for future studies to explore the dose-response relationship between CPAP use and 
positive health outcomes.  
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According to Beebe and Gozal (2002) many health care providers may be inclined 
to dismiss the psychological effects of OSAS due to a lack of understanding related to the 
link between the two. These findings will hopefully increase awareness related to the link 
between OSAS and daytime psychological consequences, especially daytime sleepiness. 
It is estimated that approximately 80 percent of persons with OSAS have a milder form 
of the disease (Young et al., 2008). Healthcare providers should routinely assess OSAS 
patients for daytime sleepiness.  
Severity of OSAS is based on the number of apnea – hypopnea episodes per hour 
of documented sleep (American Academy of Sleep Medicine, 2007). The apnea – 
hypopnea episodes result in oxygen desaturations and an increase in sympathetic activity 
(Kario, 2009). The desaturations and increased sympathetic activity result in increased 
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arterial pressure (Nieto et al., 2000; Peppard et al., 2000).  The Wisconsin Sleep Cohort 
Study found a dose response relationship between the number of apnea hypopnea 
episodes and the development of hypertension at four year follow up (Peppard et al., 
2000). Haentjens et al. (2007) found a greater reduction in blood pressure with CPAP use 
among patients with a more severe form of the disease. The progressive nature of OSAS 
requires that health care providers examine the effectiveness of treating the disease 
during the early stage to prevent untoward effects associated with the disease.  
Practice Implications  
 The implementation of EMR’s in primary care settings hold great potential for 
improving quality of care. However, the process requires effective communication and 
planning between EMR creators, physicians, nurses, and clinic / hospital assistive 
personnel (Crosson, Stroebel, Scott, Stello, & Crabtree, 2005).  Primary care settings 
present issues specific to the practice, such as treatment protocols for specific disease 
conditions. Effective implementation will require high levels of collaboration within the 
practice. Nursing is in a unique position to facilitate the adoption of EMR systems in this 
setting by working with other practice leaders to address specific implementation issues 
as they arise.  
 The transition from paper records to electronic records requires meticulous 
attention to data entry accuracy. Nursing can lead efforts with clerical staff and other 
allied health team members to clarify health related terminology questions that could 
potentially affect the quality of documentation within the medical record. Nursing is also 
in a position to lead efforts to evaluate the quality of the EMR system adopted. It is 
imperative that the EMR contain features that specifically address quality measures such 
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as blood pressure checks, smoking cessation counseling, and controlled blood pressure 
for hypertensive patients (Hsiao, Marstellar, & Simon, 2014). Hsiao et al. (2014) assert 
that EMRs that are not fully functional (i.e., measuring appropriate quality of care) are 
associated with lower odds of blood pressure checks, inappropriate urinalysis, and 
inappropriate prescribing of antibiotics for urinary related infections when compared to 
no EMR use. Nurses employed outside of inpatient facilities (e.g., schools, university 
health centers, primary care offices, health departments, employee health clinics, and 
occupational health clinics) can provide important insight in the EMR selection process 
to ensure quality data is collected. The results of this retrospective chart review confirm 
the importance of collecting quality data, because several aspects of the study design and 
analysis needed to be re-configured due to inadequacies of the EMR chart availability 
and documentation quality. Clinical decisions in research and practice in the treatment of 
OSAS are based on data collected. Incomplete or missing data can skew research findings 
and practice decision and delay advancements in areas of science that depend on chart 
reviews for uncovering those advances.  
When data are collected and entered correctly the EMR system can provide a rich 
source of clinical information, not only for point-of-care clinical practice, but also for 
research and quality performance evaluation (Tu et al. 2014). However, incomplete or 
missing data can lead to patient safety concerns as well as problems with data collection 
for research and quality evaluation. One solution to the safety concerns associated with 
lack of or incomplete data may be to implement a follow-up and feedback system such as 
the one proposed by Gandhi and colleagues to address the reporting of errors (Gandhi, 
Graydon-Baker, Huber, Whittemore, and Gustafson, 2005). Follow-up involves assigning 
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responsibility and accountability for the plan of action set forth to address specific safety 
issues. Feedback refers to following up with those who report the safety issues and 
communicating the issue and plan of action to the broader staff and clinicians 
participating in patient care. Nurses specializing in informatics should be included in the 
action plan and should be consulted when evaluating the best approach for dissemination 
of feedback to the broader audience of health care professionals.  The use of a complete 
and current EMR system in sleep clinics could potentially alert health care providers in 
this area to changes in patient conditions that could be impacted by OSAS (hypertension, 
daytime sleepiness) as well as provide current data related to CPAP use.  
Policy Implications  
 The American Recovery and Reinvestment Act (ARRA) of 2009 stimulated the 
adoption of health information technology (HIT). The law provides an unprecedented $19 
billion to promote the adoption and use of HIT. The President of the United States vowed 
to provide every American with the benefit of an electronic health record by 2014 
(Blumenthal, 2009). Physicians who adopt EMR’s in their practice are rewarded with 
financial incentives, while those who do not adopt EMR’s in their practice by 2015 will 
lose a percentage of Medicare fees. This loss will continue to increase until 2017 
(Blumenthal, 2009). The transition to EMR’s is critical to the nursing profession. 
Physicians who lose funding will likely cut back in other areas of their practice (e.g., 
staffing, salaries) which will have a direct impact on nursing. Nurses play a pivotal role 
in supporting legislation aimed at increasing the adoption rate of EMR systems. Nursing 
research is one area that stands to be enhanced from legislation promoting HIT. One 
provision of the Patient Protection and Affordable Care Act specifically addresses the 
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need for clinical registries and networks where health information data can be shared 
among health care providers (Buntin et al., 2010).  This type of registry and networking 
would facilitate nursing research that mines EMRs for linking care to quality, safety, and 
health outcomes.  
Recommendations  
 Several recommendations that are supported by the challenges experienced in this 
study are put forward. The first recommendation relates to collecting data on persons 
diagnosed with mild OSAS. Currently, data may not be consistently collected on patients 
at all levels of disease severity. OSAS is a progressive disease and aggressive early 
treatment can deter negative health outcomes associated with the disease. Increasing 
awareness among health care practitioners, particularly nurses, could lead to more 
complete and accurate documentation in persons with mild OSAS.   
 Next, it is recommended that this study be replicated using wider sampling by 
including additional sleep clinic offices. This would allow for a larger and more diverse 
sample size and could lead to more generalizability of findings.  Decreases were 
identified in daytime sleepiness and blood pressure for those who used CPAP four or 
more hours a night and for those who used CPAP less than four hours a night in this 
study but did not reach the level of significance. The small sample size likely contributed 
to low power to detect significant differences between the groups. In addition, future 
studies of this type should control for blood pressure medication use. Data should be 
obtained specific to whether a medication was taken for hypertension or another disease 
that could also be treated with blood pressure medications (i.e., vascular headaches). Data 
related to sleep hygiene, work / shift schedules, lifestyle, and alcohol use could 
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potentially offer additional valuable information related to excessive daytime sleepiness 
and hypertension in this population (National Sleep Foundation, 2013). Conducting a 
study examining a time point beyond the six week follow up may also offer plausible 
explanations related to CPAP use. Participants who used CPAP less than 4 hours night 
may have experienced more difficulty adjusting to the CPAP machine than participants 
who used greater than 4 hours a night. It is possible that study participants who used 
CPAP less than 4 hours a night may increase use over time with CPAP machine 
adjustment. A future study may also employ the use of a more rigorous measure of sleep 
quality, such as the Pittsburgh Sleep Quality Index (Sitasuwan, Bussaratid, 
Ruttanaumpawan, & Chotinaiwattarakul, 2014) or the Functional Outcomes of Sleep 
Questionnaire (Korpe, Lundgren, & Dahlstrom, 2013) and also extend follow-up data 
collection to points beyond only 6 weeks after CPAP initiation to account for the time 
needed to adapt to the machine and any machine adjustments. Findings from this study 
also recommend that future studies seeking to improve upon the study design to establish 
causal relationships between CPAP use and outcomes should also utilize random 
assignment of participants.   
 Another recommendation is related to CPAP use reporting. Future studies should 
consider using CPAP data collected at a specific time point (i.e., 30 days). It is assumed 
from this study that all machines report the same type of data, varying primarily in how 
the usage data is presented (graph, table, etc.). The results of this study do not suggest 
that one machine is better than another at providing essential data needed related to 
usage, only that data collection time points were widely variable. Standardization of 
CPAP machine use reporting in future studies would also strengthen the study. Future 
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studies may also be strengthened by obtaining CPAP summaries directly from the 
medical supply company rather than the sleep clinic office, since the sleep office may 
choose not to enter all variables from the CPAP summaries needed for research studies 
into the EMR. This method of CPAP use data collection may potentially provide 
additional information related to the dose –response relationship between CPAP use and 
possible health benefits.  
 Finally, this study recommends that nurses partner with other healthcare 
professionals in sleep medicine to define nursing’s contribution to early detection and 
treatment of OSAS. Nurses should be more integrally involved with sleep centers in ways 
that could benefit patient outcomes. The role of the nurse in identification of those with 
or at risk for developing OSAS warrants expansion. This expansion could be enhanced 
through educational opportunities aimed toward increasing awareness among nurses 
related to identifying the signs and symptoms of OSAS (i.e., snoring, morning headaches, 
and excessive daytime sleepiness) across all patient populations and across the lifespan. 
Nurses also have the capacity to be ideal providers to teach patients how to both use 
CPAP machines, but perhaps more importantly, integrate CPAP use into their lives, 
troubleshoot problems and challenges, and promote follow-up and coordination of care 
between sleep medicine specialists and other health care team members (Rodgers, 2014). 
Furthermore, nurses may also play a pivotal role in educating patients regarding sleep 
hygiene (practices associated with sleep) and modifications to the sleep environment 
(www.nationalsleepfoundation.org). Patient education regarding sleep practices that 
potentially interfere with sleep such as ingesting stimulants prior to bedtime (alcohol, 
caffeine, nicotine), staying in the bed too long or not long enough, food intake and 
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exercise regimen close to bedtime, and not creating a relaxing environment prior to 
bedtime could potentially result in higher quality sleep and potentially lead to enhanced 
outcomes of CPAP therapy. Aggressive, early identification and treatment of OSAS is 
crucial to slowing the progression of the disease and promoting the health of persons 
experiencing this disease.  
Conclusion  
Knowledge regarding the effectiveness of CPAP use in persons with mild OSAS 
and daytime sleepiness and blood pressure is critical to the treatment of this population. 
This evidence is needed to demonstrate the need to intervene and treat early in the disease 
process. The results of this study do not support the use of CPAP therapy in persons with 
mild OSAS; however, this finding should be interpreted cautiously given the results were 
limited by several methodological issues. The question of when to implement CPAP as 
treatment for a person with OSAS has long been debated (Barnes et al., 2002). Although 
the results of this study did not reach the level of statistical significance, it should be 
noted that a reduction in daytime sleepiness and blood pressure was identified in both 
groups, irrespective of amount of CPAP use.  
 A retrospective chart review was used for this study employing an analysis of 
patient electronic medical records from a local sleep clinic in the southern United States. 
The challenges encountered in the collection of the patient data had a major impact on the 
outcome of this study. Sample size was severely limited as a result of incomplete or 
missing data. These issues suggest that greater attention be given to securing adequate 
collecting and input of data into EMR in persons with mild OSAS.  
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 This study found no evidence to support the use of CPAP in persons with mild 
OSAS. The reductions noted in daytime sleepiness and blood pressure did not reach the 
level of statistical significance. The results from other studies examining the effect of 
CPAP use on blood pressure and daytime sleepiness in the mild OSAS population are 
conflicting. The results of this study and the findings of other studies (contradictory, little 
effect, no effect) support the need to question when to implement CPAP as treatment for 
OSAS.  
It is crucial for the nursing profession to continue to conduct methodically sound 
research examining the effect CPAP use has on patients with mild OSAS. Nursing needs 
to be concerned with evolving existing research in the area of OSAS and expanding the 
knowledge base related to treating persons with mild OSAS. This is a responsibility the 
nursing profession should embrace, since nurses both care for patients with OSAS and 
may be best positioned to understand how to promote the self-management of OSAS and 
CPAP to optimize health outcomes.  
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Appendix C.  
Epworth Sleepiness Scale  
Situation Chance of Dozing 
0 = would never dose, 1= slight chance of 
dozing, 2= moderate chance of dozing, 3= 
high chance of dozing 
Sitting and reading  
Watching TV  
Sitting, inactive, in a public place  
As a passenger in a car for an hour  
Lying down in the afternoon  
Sitting and talking to someone  
Sitting quietly after a lunch without alcohol  
In a car, while stopped for a few minutes in 
traffic 
 
Total  
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